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Summary 
Hyperactivation is a movement pattern elicited by sperm in the female reproductive tract. 
The transition to hyperactivated movement is characterised by an increase in amplitude 
and a decrease in symmetry of flagellar bending. The resulting forceful, unequal waveforms 
produce a swimming style that is erratic and often non-progressive.  Linked temporally with 
the process of capacitation, hyperactivation is thought be a pre-requisite for fertilisation. 
Its putative roles are in navigation and movement through the oviduct, infiltration of the 
cumulus oophorus and penetration of the zona pellucida. The majority of evidence for the 
requirement for mammalian hyperactivation has emerged from studies in the mouse and 
the hamster, however a number of clinical studies in humans have also suggested that its 
expression is linked to male fertility both in vivo and in vitro. The expression of 
hyperactivation appears to be controlled both by Ca
2+ 
entry through plasma membrane 
CatSper channels and by Ca
2+ 
release from intracellular stores. Using CASA, the efficacy of 
pharmacological agents known to influence hyperactivation was assessed, and a robust 
hyperactivation assasy was developed. The assay was used both to explore the incidence of 
hyperactivation in fertile and infertile populations of men, and to attempt to define the 
prognostic potential of a pre-IVF hyperactivation screen. Whilst sperm from men 
undergoing ICSI treatment exhibited lower levels of hyperactivation than sperm from men 
in whom no semen abnormalities could be identified, there was no correlation between 
hyperactivation and fertilisation rate in conventional IVF. In the final set of experiments, an 
attempt to affirm the role of store-operated Ca
2+
 entry in hyperactivation was made, 
however drugs known to modulate this pathway did not influence any sperm motility 
parameters.       
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Chapter 1: Regulation and function of sperm motility and hyperactivation in humans 
1.1 A sperm cell’s journey to the oocyte 
Crucial to achieving fertilisation in vivo is the ability of sperm to travel from their point of 
deposition in the female tract to the oviductal ampulla, where, if ovulation occurs, they will 
encounter the oocyte. Delivery of their genetic material involves an arduous journey for 
these cells, and although hundreds of millions of sperm may be ejaculated by the human 
male, only tens, or at the very most hundreds, will complete it (De Jonge, 2005). 
 
 
Figure 1.1: The female reproductive tract. Adapted from image on (www.nursingcrib.com, 
2011). 
 
Following spermatogenesis in the seminiferous tubules, human sperm are transported to 
and stored in the epididymis, the site at which they undergo their final stages of 
maturation (Bjorndahl et al., 2010). At ejaculation during coitus they are expelled from the 
urethra in prostatic fluid. Together the sperm and prostatic components form the first 
portion of the ejaculate (Kvist, 1991). Large numbers of cells may be lost to backflow, but 
the remainder escape this hostile, acidic environment by quickly beginning to swim out 
from seminal plasma into the cervix via the external os, from which mucus to ‘catch’ the 
 
Uterus 
Oviduct 
Os 
Ampulla 
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sperm emanates (Suarez and Pacey, 2006). During the peri-ovulatory period, the cervical 
glands produce mucus which is more hydrated than at other times of the menstrual cycle 
(Morales et al., 1993; Katz et al., 1997). Despite this enhanced receptivity to sperm, only 
cells which are morphologically normal and moving with sufficient velocity in a forward 
progressive manner will adeptly traverse the cervix (Hanson and Overstreet, 1981; Katz et 
al., 1990).  
 
Contractile activity of the myometrium and/or the action of uterine cilia, may encourage 
the flow of sperm into the uterine cavity (Suarez and Pacey, 2006; Elder and Dale, 2011). To 
avoid attack by leukocytes, which will enter the uterus following ejaculation, it may be 
important for sperm to progress to the uterotubal junction quickly (Suarez and Pacey, 
2006). 
  
The lumen of the uterotubal junction is narrow, folded and contains oestrogen-dependent 
viscous mucous which flows in the opposite direction to sperm movement (Jansen, 1980; 
Bjorndahl et al., 2010). Whilst sperm inherently swim against currents, the junction may 
represent an additional system by which to ‘filter out’ poorer quality sperm (Mortimer, 
1997). Human sperm have been seen to bind intermittently to the epithelial cells in the 
isthmic portion of oviduct (Pacey et al., 1995; Pacey et al., 1995; Baillie et al., 1997), an 
interaction which may both prolong sperm survival (Kervancioglu et al., 1994) and limit 
their passage through the tubes, thereby reducing the incidence of polyspermy (Suarez and 
Pacey, 2006). 
 
Components of follicular fluid or secretions from the mature ooctye and its vestments may 
then guide the sperm chemotactically towards the exact site of fertilisation (Eisenbach, 
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1999; Sun et al., 2005). The time from insemination to fertilisation has been proposed to be 
at least one hour, and up to as many as five days (Suarez and Pacey, 2006). 
 
1.2 Fertilisation 
The in vivo fusion of the mature male and female gametes involves a sophisticated and 
highly ordered series of events. With respect to the role of the spermatozoon, completion 
of the following steps is crucial: 
 
1. Acquisition of a ‘capacitated’ status, at some point between the cervix and the 
oviductal ampulla 
2. Passage through the jelly-like matrix of the cumulus oophorus surrounding the 
oocyte 
3. Specific binding to the zona pellucida, a glycoproteinous capsule which directly 
coats the oocyte 
4. Exocytosis of acrosomal contents, a process which renders the sperm plasma 
membrane capable of interacting with the oolemma  
5. Penetration of the zona pellucida 
6. Binding to and fusion with the oolema 
 
Compiled using information from (Johnson, 2007; Publicover et al., 2007). 
 
Following membrane fusion, the soluble sperm-oocyte activating factor, phospholipase 
zeta, promotes the opening of Ca
2+
 stores in the ooplasm which create calcium ion 
transients. The cortical granule reaction and vitelline block prevent polyspermy, the sperm 
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nucleus moves to the oocyte cortex and begins to decondense, and meiosis is reinitiated 
(Johnson, 2007). 
 
The use of in vitro fertilisation entirely eliminates the barrier posed to sperm by the female 
reproductive tract. During conventional IVF, penetration of the cumulus oophorus and the 
zona pellucida by sperm are still absolute requirements for fertilisation. By employing intra-
cytoplasmic sperm injection, these lattermost obstacles are also removed, allowing even 
the most severely compromised sperm access to the ooplasm.  
 
1.3 Flagellar architecture and the controls of sperm motility 
The flagellum, responsible for the propulsion of sperm through the female reproductive 
tract, comprises the connecting piece, midpiece, principal piece and end piece. Motility is 
generated by the axoneme, a structure which runs through the centre of the sperm tail and 
is supported by a protective cytoskeletal sheath (Figure 1.2).  
 
 
Figure 1.2: Cross section through the axoneme. From (Mortimer, 2000). 
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In a classical arrangement, two central single microtubules are surrounded by nine 
peripheral microtubule doublets (Inaba, 2003). Nexin links connect the doublets to each 
other, and radial spokes bridge the outer nine microtubules and the central pair (Mortimer, 
1997). The connecting piece at the base of the flagellum is fused with outer dense fibres, 
linking the tail and the head (Fawcett, 1975). Movement is enabled by the accessory 
protein dynein, which forms distinct ‘arms’ on the peripheral doublets and whose ATPase 
activity provides the mechanical energy required to ‘walk’ one microtubule doublet along 
an adjacent one via the sequential making and breaking of attachments (Mortimer, 1997). 
The inner dynein arms confer flagellar waveform and beat symmetry, and the outer arms 
establish the maximal velocity of outer doublet movement (De Jonge and Barratt, 2006). 
Localised sliding of microtubules creates bending in the flagellum, and the asymmetry of 
the axoneme and the sequence of attachments result in waves that appear helical, but are 
not quite (Mortimer, 1997). Beat frequency is controlled at the base of the flagellum, and 
waves that propagate backwards to create forward propulsion (Mortimer, 1997; Oehninger 
and Kruger, 2007).  
 
Sperm cells acquire the ability to swim during their transit through the epididymis, and 
motility becomes ‘activated’ when they come into contact with seminal plasma at 
ejaculation (Oehninger and Kruger, 2007). Extrinsic factors such as the extracellular ionic 
environment and specific components present in semen and the female reproductive tract 
are responsible for initiating and maintaining sperm motion.  
 
Secreted by the prostate gland, and important for pH buffering in the vagina, the 
bicarbonate ion plays a crucial role in switching on and maintaining sperm motility 
(Wennemuth et al., 2003), whose primary roles are outlined in the Figure 1.3. 
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Figure 1.3: Biochemical control of sperm motility in humans. Compiled using information 
from (Luconi and Baldi, 2003; De Jonge and Barratt, 2006).  
 
Cyclic AMP and Ca
2+
 are the key second messenger molecules involved in the initiation and 
regulation of sperm motility (Luconi and Baldi, 2003; Esposito et al., 2004). The rise in pH 
promotes the opening of alkaline-dependent Ca
2+ 
channels, which, along with Ca
2+ 
flux 
through voltage-gated channels, raise [Ca
2+
]i . Calcium ions form a calcium/calmodulin 
complex which interacts with a number of enzymes, including cyclases, phoshatases and 
kinases (Jaiswal and Conti, 2003; Ignotz and Suarez, 2005; Marin-Briggiler et al., 2005). 
cAMP activates protein kinase A (PKA), which phosphorylates serine or threonine reisdues 
on proteins. Eventually, this in turn results in the tyrosine phoshorylation of axonemal 
proteins, and axonemal sliding is translated into flagellar waves (Mortimer, 1997; Suarez, 
2008). Protein kinase C may also be involved in the regulation of sperm motility (De Jonge 
and Barratt, 2006). The ATP requirement for sperm motility can be derived from both 
H
+
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17 
 
oxidative phosphorylation and anaerobic glycolysis, with the former maximising output per 
glucose molecule, but the latter minimising the production of membrane-damaging 
reactive oxygen species (Nascimento et al., 2008; Storey, 2008).  
 
1.4 Hyperactivation 
Microscopic observation of a normal fresh semen sample reveals activated cells travelling 
in a forward progressive, linear trajectory (Robertson et al., 1988). Responsible for this 
pattern of motility are roughly symmetrical flagellar waveforms of relatively low amplitude. 
First observed in the laboratory by Yanagimachi during his work on hamster sperm 
(Yanagimachi, 1970), the motility pattern ‘hyper-activation’ has since been noted in all 
Eutherian mammalian sperm examined, including humans (Burkman, 1984). 
Hyperactivation involves the generation of high amplitude asymmetrical bends in the 
proximal midpiece, propagation of which along the length of the flagellum results in 
vigorous tail movements and unequal waveforms (Mortimer, 1997). The result in 
mammalian sperm is a reduced linearity of the sperm trajectory, but an increase in thrust 
(Suarez et al., 1991).  
18 
 
 
Figure 1.4: Beat pattern in activated vs hyperactivation sperm. ‘A’ = progressive sperm, 
‘B’= hyperactivated sperm. Image from (Suarez, 2008). 
  
 
A reversible phenomenon, hyperactivation becomes initiated in the oviduct of mammalian 
species (Katz et al., 1989; Mortimer and Swan, 1995; Suarez and Pacey, 2006). Rabbit 
sperm  recovered from the ampulla were observed to swim in circles, a characteristic 
trajectory produced by asymmetric bending (Suarez et al., 1983). In the hamster, 
hyperactivated sperm have even been observed ‘in situ’ through the transparent wall of 
the oviduct (Katz and Yanagimachi, 1980). The pH and ionic environment of the oviduct are 
supportive of hyperactivated motion, and follicular fluid has been shown to promote its 
expression (Fabbri et al., 1998). The propulsion generated by this whiplash-like tail 
movement has been associated with sperm fertilising potential, both in vivo and in vitro, in 
animals (Ren et al., 2001; McPartlin et al., 2009), and in humans (Johnston et al., 1994; 
Sukcharoen et al., 1995).  
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Removal of sperm from seminal plasma, in which ‘decapacitation’ factors actively prevent 
premature sperm maturation (Chang, 1957), and re-suspension in a medium containing the 
necessary biochemical requirements, allows hyperactivation to be observed in vitro. 
Interestingly, hyperactivation in semen is actually associated with raised levels of the 
superoxide ion (de Lamirande and Gagnon, 1993), rendering its ready expression a possible 
negative factor under these conditions. Hyperactivation in vitro is supported when sperm 
are suspended in a medium containing at least 25mM bicarbonate, excess exogenous 
calcium ions and an energy source such as glucose. Other factors present in culture media 
may also support hyperactivation, such as taurine and a protein source such as human 
serum albumin or bovine serum albumin (Mortimer, 1997).  
 
When free swimming human sperm are suspended in a low viscosity medium designed to 
support capacitation, two distinct patterns of hyperactivation can be observed. The first is a 
swimming style in which cells move generally forward, but via the production of very wide 
lateral displacements of the sperm head. This is referred to by some investigators as 
‘transition phase’ (Mortimer and Swan, 1995). The second category of hyperactivation is a 
step up from this; movements are even more dramatic, and produce patterns described as 
‘figure-of-eight,’ ‘thrashing,’ ‘helical’ or ‘star-spin’ (see Figure 1.5). In this case tail beating is 
so asymmetrical that cells move on the spot rather than in a space gaining manner 
(Robertson et al., 1988; Mbizvo et al., 1990; Mortimer and Swan, 1995).  
 
If sperm are exposed to a medium of high viscosity, the amplitude of flagellar bending is 
automatically reduced (Suarez and Dai, 1992; Mohri, 1993). Hyperactivated movement in 
fact becomes translated into forward progression, presumably because much of force of 
the thrust has been absorbed. For example, when sperm cells enter the cumulus, their 
20 
 
movement changes in response to the viscoelasticity of the matrix; beat frequency and 
flagellar curvature are reduced, and sperm move progressively, albeit slowly (Mortimer, 
1997). Sustaining hyperactivated movement requires increased energy production by the 
cell (Luconi and Baldi, 2003). Importantly, the extra ATP is used specifically to enhance 
flagellar curvature and not to increase tail beat frequency. The frequency of flagellar 
beating is actually reduced in hyperactivated cells (Mortimer and Mortimer, 1990).    
 
 
Figure 1.5: Human sperm in ‘star spin’. Observed using Computer Assisted Sperm Analysis 
during an experiment carried out in Chapter 4. 
 
1.5 Capacitation 
Freshly ejaculated mammalian sperm are unable to fertilise eggs immediately, and instead 
require a prior incubation period in the female reproductive tract (Austin, 1951; Chang, 
1951). To become ‘capacitated’ (Austin, 1952) sperm cells undergo a highly complex 
process of signal transduction, culminating in biochemical, molecular, physiological and 
structural alterations that render them fully mature and capable of interaction with an 
oocyte (De Jonge and Barratt, 2006). Capacitation is temperature dependent, occurs over a 
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period of hours, and is a reversible process. In the laboratory it can be induced with the use 
of a medium designed to mimic the oviductal lumen (De Jonge, 2005). Hyperactivated 
motion is usually considered a concomitant of capacitation, and the expression of 
hyperactivation may serve as a visual marker by which to identify a capacitation-supportive 
medium. However, whilst the two processes are certainly linked temporally, it is unclear to 
what degree their signalling pathways are shared. Plasma membrane changes brought 
about by capacitation may increase cell permeability to ions involved in controlling motility, 
and tyrosine phoshorylation of axonemal proteins by PKA, a downstream event of 
capactitation, may impart the flexibility required for increased flagellar bending (Mariappa 
et al., 2010). However, there is evidence, both in the bovine and the human, that 
hyperactivation can occur completely independently of capacitation, suggesting that they 
are regulated separately, or at least that the signalling pathways diverge at some point (Ho 
and Suarez, 2001; Marquez and Suarez, 2004; Bedu-Addo et al., 2008).  
 
1.6 Function of hyperactivation 
Hyperactivation has been associated with sperm fertilising potential both in vivo and in 
vitro, and in animals and humans. Four primary roles for hyperactivation have been 
postulated, as outlined below: 
 
1. Effective passage through viscous oviductal mucous  
Experiments in the hamster demonstrated that hyperactivated cells pass more 
efficiently through viscous medium than those which are not (Suarez et al., 1991). The 
lumen of the oviduct in mammals is filled with viscous fluid and mucus secretions 
(Jansen, 1980), and hyperactivation may facilitate movement through such secretions. 
Whilst the cervix also contains mucus, hyperactivation is unnecessary at this point, 
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possibly because the mucus is thinner, or because pressure changes assist sperm 
progress at this stage of the tract (Suarez and Dai, 1992). 
  
2.  Prevention from becoming trapped by epithelial wall of oviduct 
Circular trajectories resulting from hyperactivation may allow sperm to change 
direction and prevent them from becoming trapped in the crypts which line the 
epithelial wall of the tubes, allowing easier progression towards the oocyte. 
Interestingly, human sperm in vitro have also been observed to seemingly deliberately 
bind to the endosalpingeal epithelium (Pacey et al., 1995; Pacey et al., 1995; Baillie et 
al., 1997). Functionally this may represent a mechanism by which to hold sperm in a 
senescent state and preserve their motility, for example if insemination has preceded 
ovulation (Bjorndahl et al., 2010). Another reasonable explanation for this 
phenomenon may be that, by letting sperm reach the ampulla in only small numbers at 
a time, the chances of polyspermic fertilisation are reduced. Sperm must of course be 
able to free themselves from these interactions at the appropriate time, and a putative 
method of accomplishing this is via the generation of deep and forceful thrusts, i.e. by 
hyperactivating (Suarez, 2008). In the mouse, only hyperactived sperm were observed 
to detach from the oviductal epithelium (Demott and Suarez, 1992). Similarly, sperm 
from mice which completely lacked the biological capacity to induce hyperactivation 
were unable to progress beyond the oviductal sperm reservoir in vivo (Ho et al., 2009).  
 
3. Infiltration of the cumulus oophorus 
During the antral phase of follicular growth a dense layer of granulosa cells surrounds 
the oocyte and supports its development within the follicle. These cells persist after 
ovulation, and together with hyaluronic acid linked by proteins, make up the huge 
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cumulus oophorus matrix (Johnson, 2007). Penetration of this elastic meshwork seems 
to require the application of specific mechanisms by sperm cells. For example, sperm 
surface-bound hyaluronidase enzymes may degrade hyaluronic acid (Kim et al., 2008), 
and the sheer mechanical force imparted by hyperactivated motility may also confer an 
advantage. In the mouse, it was demonstrated that hyperactivated sperm moved 
through medium containing polyacrylamide (which is of a similar viscoelasticity to the 
cumulus matrix) with greater speed and linearity than activated sperm (Suarez and Dai, 
1992). 
      
4. Penetration of the zona pellucida  
The protective outer coat of the oocyte, composed of glycoproteins, presents the final 
barrier that sperm must overcome to reach the oolemma. Specific binding of 
capacitated sperm heads to the surface of the zona pellucida causes the proteolytic 
contents of the acrosomal store to be exocytosed (Johnson, 2007). These enzymes may 
have a role in dissolving a path through the zona pellucida (Florman et al., 2008). 
However, the significance of this lytic function is debated. In mammals a proportion of 
sperm will release their acrosomal contents prior to even reaching the surface of the 
egg (Bedford, 1998), and in the mouse, sperm entirely deficient of acrosin can 
nonetheless breach the zona and fertilise eggs (Baba et al., 1994). Mathematical 
calculations have also shown that the force generated by non-hyperactivated sperm 
would be insufficient to break the bonds between the sperm head and the zona 
proteins, and that hyperactivation would provide the necessary mechanical power for 
the sperm to wriggle or drill through the zona (Green and Purves, 1984; Patrizio et al., 
2000). The most conclusive evidence for the role of hyperactivation as the predominant 
mechanism of zona penetration comes from studies in the hamster and the mouse. 
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When hyperactivation was abolished, either by manipulating the culture medium or by 
creating knockout mice for a gene which is essential for this type of movement, in vitro 
fertilisation of zona-intact oocytes was completely prevented (Stauss et al., 1995; Ren 
et al., 2001). Similarly, in the equine, only sperm samples which hyperactivated in 
response to an inducer were able to fertilise oocytes in vitro (McPartlin et al., 2009).   
 
1.7  Chemotaxis 
Sperm from marine invertebrates use chemotaxis to locate oocytes and fertilise them 
externally (Eisenbach, 1999). A potential role for this type of chemical guiding mechanism 
also exists in mammals, and a number of studies have reported an attraction of sperm to 
the oocyte-cumulus complex and follicular fluid (Ralt et al., 1991; Wang et al., 2001; Sun et 
al., 2005). The aromatic aldehyde bourgenal has been shown to activate olfactory 
receptors found in human sperm, and to induce chemotaxis by influencing the generation 
of cAMP, which in turn may open Ca
2+
 channels and modify flagellar movement (Spehr et 
al., 2004). An equivalent endogenous stimulant has not been identified. Progesterone is, in 
fact, the most likely candidate molecule for inducing this change in human sperm 
behaviour in vivo (Villanueva-Diaz et al., 1995; Teves et al., 2006; Gakamsky et al., 2009). A 
tentative model for the molecular signalling pathway underlying the chemotactic response 
of mammalian sperm involves both the activation of adenylate cyclase and guanylate 
cyclase, followed by tyrosine phosphorylation of flagellar proteins and mobilisation/influx 
of Ca
2+
 (Teves et al., 2009). It is still disputed, however, whether this ability of progesterone 
to draw sperm towards the oocyte is representative of specific movement along a 
concentration gradient (true chemotaxis), or non-specific changes of direction caused 
simply by induction of hyperactivation. The latter effect is chemokinesis, not chemotaxis, 
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however it would nonetheless hold the sperm in one place and allow them to ‘search’ for 
the cumulus (Jaiswal et al., 1999).       
 
1.8 Ca
2+
 signalling in sperm 
Mature sperm cells are compact and highly motile. In order to achieve this status they are 
forced to sacrifice much of their cytoplasmic volume and condense their nucleus. With 
largely inaccessible DNA and no endoplasmic reticulum, sperm are thought to be 
transcriptionally and translationally silent (or at least very quiet) (Costello et al., 2009). To 
therefore respond to external signals they rely heavily on post-translational modification of 
proteins via second messengers, the most crucial of which is intracellular calcium ion 
concentration, [Ca
2+
]i (Publicover et al., 2007). Aberrant Ca
2+ 
signalling may contribute to 
impaired function in terms of cell maturation, acrosome reaction and hyperactivation 
(Evans and Florman, 2002; Kirkman-Brown et al., 2002; Suarez and Ho, 2003).  
 
1.9 Role of Ca
2+
 in generation of hyperactivation   
A comprehensive overview of the signalling pathway is yet to be elucidated, but cytosolic 
Ca
2+ 
concentration in the vicinity of the midpiece and tail is known to be the critical 
regulator of hyperactivated motility in mammalian sperm (Ho et al., 2002; Harper et al., 
2004; Suarez, 2008). Demembranated-reactivated bull sperm models have shown that Ca
2+
 
acts directly on cytoskeletal components of the axoneme (Ho et al., 2002), binding to 
calmodulin or calmodulin-binding proteins to modify proteins which influence curvature 
(Ignotz and Suarez, 2005). The extra energy required for hyperactivation is derived from an 
increased consumption of ATP by axonemal components (Ho et al., 2002).  
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Ca
2+
 for hyperactivation can be sourced from the extracellular environment, and it will 
move readily into the cell down its electrochemical gradient. A variety of Ca
2+
-permeable 
channel families have been identified in the sperm flagellum, which in both mice and 
humans include classical voltage-gated, cyclic nucleotide-gated and transient receptor 
potential. Each could potentially play a role in the regulation of sperm movement and 
hyperactivation (Darszon et al., 2006; Suarez, 2008). The family of genes which code for the 
proteins of the ‘CatSper’ channels, however, are the only plasma membrane channels that 
have been identified as fundamental for the generation of appropriate sperm movement, 
and in particular the expression of hyperactivation (Ren et al., 2001). 
 
 1.10 CatSpers 
Genes belonging to the CatSper family, discovered in the last decade through studies in 
knockout mice, are expressed exclusively in the testes and have been found to play a 
critical role in mammalian male fertility (Quill et al., 2001; Ren et al., 2001; Carlson et al., 
2003). Mice which are null for CatSper1, 2, 3 or 4 are healthy, undergo normal 
spermatogenesis and produce standard concentrations of swimming sperm, but are 
infertile (Ren et al., 2001; Jin et al., 2005; Jin et al., 2007; Qi et al., 2007). Only in vitro and 
with the prior removal of zona pellucidae can sperm from CatSper null mice fertilise eggs 
(Ren et al., 2001). 
 
The gene products of the CatSpers contain six-transmembrane-spanning regions and are 
thought to form a tetrameric cation channel which localises to the plasma membrane at 
the principal piece of the sperm tail (Kirichok et al., 2006; Qi et al., 2007). Patch clamping 
studies in human sperm have recently revealed that progesterone, secreted by the 
cumulus cells surrounding the egg, facilitates the opening of these voltage-sensitive and 
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alkaline-dependent CatSpers, either through direct binding to the channel itself, or via a 
subunit (Lishko et al., 2011; Strunker et al., 2011). 
 
Abrogation of ICatSper, the current which flows through the channel, disrupts sperm motility 
(Carlson et al., 2003). Sperm from CatSper null mice are motile upon ejaculation, but this 
motility is unsustainable. Crucially, the ability of the tail to beat and bend more forcefully, 
and therefore also the initiation and maintenance of hyperactivatation, is lost completely 
(Ren et al., 2001; Carlson et al., 2003; Qi et al., 2007).  
 
CatSper studies have also been carried out in humans, although these are limited. 
Investigations conducted on the genetics of brothers, apparently with consanguinity in 
their family, revealed a human CATSPER2 homologue at loci 15q. The inheritance of two 
mutated copies of this autosomal gene resulted in non-syndromic male infertility (Avidan 
et al., 2003). These men produced semen which was normal with respect to volume and 
sperm concentration, but was asthenoteratozoospermic. Less than 3% overall motility 
was observed, and sperm tails were short and coiled. In 2009, mutations were also 
identified mutations in the CATSPER1 loci (chromosome 11) in humans, again via studying 
men from consanguineous families presenting with infertility (Avenarius et al., 2009). 
These men, however, as well as having asthenoteratozoospermia, also produced low 
volume ejaculates with low sperm concentrations, suggesting that in this case either 
disruption of motility may not be the sole role of human CATSPER1, or there were other 
underlying reasons for the suboptimal spermatogenesis. Another study, which analysed 
transcripts of CatSper from testicular tissue of men undergoing surgery either for a 
testicular biopsy or orchidectomy, found significantly lower levels of CatSper gene 
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expression in men for whom a motility disorder was causing them to be infertile (Nikpoor 
et al., 2004).  
 
1.11 Intracellular Ca
2+
 stores and hyperactivation                                            
In somatic cells, which use changes in intracellular calcium ion concentration to control 
numerous biochemical processes, sophisticated temporal and spatial calcium signals can be 
generated in order to regulate complex Ca
2+
-mediated processes (Berridge et al., 2000). 
These cells make use of organelles such as the endoplasmic reticulum to store calcium ions 
internally, the subsequent release of which helps to active discrete responses (Michelangeli 
et al., 2005). Sperm in comparison are cytoplasmically very simple, yet they can also 
generate distinct patterns of Ca
2+
signals in different regions of the cell, bestowing on it a 
degree of compartmentalisation. For example, although both mechanisms involve a rise in 
Ca
2+
, hyperactivation and the acrosome reaction can occur independently in both hamster 
and human sperm (Suarez and Dai, 1995; Harper et al., 2004).  
 
Whilst sperm lack endoplasmic reticulum, they are still able to store calcium ions. The 
acrosomal store, that is the acrosome itself, has been well characterised in both mice and 
humans (Florman et al., 1998; Herrick et al., 2005; Bedu-Addo et al., 2007). However, more 
recent evidence has pointed to the existence of an additional storage organelle responsible 
for accumulating calcium ions at the neck/midpiece region of mammalian sperm. 
  
In bull sperm, the application of thapsigargin, which depletes internal Ca
2+
 stores via its 
inhibition of SERCA (an ATPase channel responsible for Ca
2+
 uptake), initiated a 
modification in flagellar bend amplitude and symmetry (Ho and Suarez, 2001; Ho and 
Suarez, 2003). An effect on flagellar bending was noted even when extracellular calcium 
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was unavailable, indicating that the additional cytosolic Ca
2+
 could only have originated 
from inside the cell (Ho and Suarez, 2001). In mice, knockouts which were null for Catsper1 
and Catsper2 were able to induce hyperactivation upon application of the store mobilising 
agent thimerosal, although this was unsustainable (Marquez et al., 2007). 
 
Presenting human sperm with a logarithmic progesterone concentration gradient (0-3µM) 
caused a slow elevation of [Ca
2+
]
i 
in a sub-population of cells (Harper et al., 2004; Bedu-
Addo et al., 2007). In some of these cells, Ca
2+ 
oscillations were superimposed on top of this 
signal (Harper et al., 2004; Kirkman-Brown et al., 2004; Harper et al., 2005). Occurring 
specifically at the neck/midpiece region, the peaks of these oscillations coincided with 
periods of enhanced flagellar excursion, and the troughs with a subsequent relaxation 
(Harper et al., 2004; Bedu-Addo et al., 2008; Machado-Oliveira et al., 2008). In a similar 
scenario to that described above in the bull, Ca
2+
 oscillations in human sperm were 
unaffected by the depletion of extracellular Ca
2+
, but sensitive to EGTA, an agent known to 
chelate cytoplasmic calcium ions (Kirkman-Brown et al., 2004; Machado-Oliveira et al., 
2008). The oscillations were proposed to represent cyclic mobilisation and re-filling of the 
Ca
2+
 store (Harper et al., 2004). 
 
Known to induce Ca
2+
 store mobilisation in other cells, when 2mM 4-AP was added to 
human sperm cells it also appeared to mobilise the store at the neck/midpeice (Grimaldi et 
al., 2001; Gu et al., 2004; Bedu-Addo et al., 2008). Moreover, the rise in Ca
2+
 that this 
induced corresponded with a tenfold increase in hyperactivation in a population of cells, 
indicating that 4-AP may be the most powerful inducer of hyperactivation yet discovered.     
 
Pharmacological manipulations of human sperm have indicated that the ryanodine-
receptor may be responsible for gating the store (Harper et al., 2004), pointing to a 
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mechanism of calcium-induced calcium release (CICR) (Harper et al., 2004). Conversely, in 
bull sperm, store opening appears to be regulated by IP3 and store-localised IP3 receptors 
(Ho and Suarez, 2001). The redundant nuclear envelope is the structure most likely to be 
responsible for accumulating the calcium ions, and indeed the storage organelle secretory-
pathway Ca
2+
-ATPase (SPCA) has been localised to this region of human sperm (Harper et 
al., 2005).  
 
Recent work in human sperm has shown that some of the components required for Ca
2+
 
signalling via the neck/midpiece store may be acquired by human sperm via prostasomes 
(Park et al., 2011; Ren, 2011). Prostasomes are very small, membranous, prostate-derived 
vesicles which are ejaculated along with sperm. Interaction between prostasomes and 
sperm is potentiated by an acidic environment, so when they become mixed together in 
the vagina, prostasomes can fuse with the sperm plasma membrane and deliver to the cell 
proteins which promote ryandodine-receptor activation, the ryanodine receptor itself, and 
SPCA1. Fusion was concentrated around the midpiece of the sperm (Park et al., 2011), 
perhaps with a view to arming the Ca
2+
 store in that location. This novel discovery will lead 
to further exploration of the putative role of aberrant prostasome-sperm fusion with 
deficiencies in motility. 
 
Therefore, whilst its identity and precise mode of operation are as yet unclear, since 
flageller beating is initiated at the anterior part of the sperm tail, a midpiece store is ideally 
placed to provide calcium ions to the axoneme for the modulation of flagellar bending. 
Sperm have the ability to rapidly switch between hyperactivated and activated motility, for 
example to ‘burrow’ through the zona pellucida (Mortimer and Swan, 1995; Bedford, 
1998). The mobilisation of stored calcium ions represents an elegant method by which 
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sperm could regulate such events, and enable quick and reversible bouts of hyperactivated 
motility.  
 
In conclusion, it seems that a model for the induction, maintenance and modulation of 
hyperactivation involves the combination of both Ca
2+ 
influx at the plasma membrane, 
primarily from CatSpers, plus Ca
2+
-release from an internal store. Recent observations in 
mouse studies have generated the interesting hypothesis that CatSper activation may 
produce bending in one direction, through phosphorylation of tail proteins, whereas store-
mobilisation may reverse this bending via dephosphorylation. If such activities were to 
enable direction changes in the female reproductive tract, then it may be that CatSpers and 
storage organelles are directly involved in navigation and/or chemotaxis (Chang and 
Suarez, 2011).    
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Chapter 2: Introduction to the assessment of hyperactivation for clinical purposes 
2.1 Infertility in men 
Male factor infertility is a significant, and, it has been suggested, increasing global problem 
(Sharpe and Irvine, 2004). Aberrant spermatogenesis and/or inadequate sperm function is 
implicated in around 40% of subfertility cases, either in isolation, or in conjunction with a 
female component (Simon et al., 2010). 
 
2.2 Asthenozoospermia 
Inadequate generation of motility, termed asthenozoospermia, can cause infertility in 
males. A retrospective, large-population study on motility related subfertility revealed that 
some degree of motility problem afflicted approximately 80% of infertile men (Curi et al., 
2003). Approximately 20% of men in the study had asthenozoospermia in isolation, i.e. no 
other sperm defects were apparent at semen analysis (Curi et al., 2003). Severe motility 
dysfunction may be caused by defective flagellar architecture, either through non-specific 
structural anomalies or congenital diseases causing ciliary dyskinesia, such as Kartagener’s 
syndrome (Chemes et al., 1998; Chemes, 2000). Usually responsible for less pronounced 
forms of asthenozoospermia, membrane damage by reactive oxygen species and inefficient 
operation of signalling pathways can also impact negatively on sperm motion (Calamera et 
al., 2003). Whilst there is limited data to show that drugs such as L-acetyl-carnitine, and 
even pure FSH (Acosta et al., 1992), can improve motility parameters in patients presenting 
with idiopathic asthenozoospermia (Balercia et al., 2005), by far the most effective and 
most employed treatment for most types of male infertility is assisted reproductive 
technology.     
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2.3 Semen analysis 
Pathologies of sperm motility are largely diagnosed during a standard, ‘descriptive’ 
laboratory semen analysis. A basic analysis of seminal fluid will usually comprise a 
macroscopic examination of the ejaculate, which indicates if semen production is being 
carried out normally, followed by a microscopic examination of all the cells, in particular of 
course the sperm. The values for sperm concentration, percentage motility and percentage 
normal morphology are then compared against reference criteria endorsed by the World 
Health Organisation (WHO, 2010). With respect to motility, the focus is on the absolute 
number, or the proportion, of forward progressive sperm in semen, which has been shown 
to be an important determinant of fertility in vivo (Barratt et al., 1992). Specifically, the 
number of sperm moving with high linear velocity, whilst simultaneously exhibiting 
moderate lateral deviation of the sperm head, has been associated with the ability of a 
sample to colonise the cervix following ejaculation and migrate through cervical mucus 
(Aitken et al., 1986; Mortimer et al., 1986). Such a measure, however, provides no direct 
insight into how sperm will move in the upper part of the female reproductive tract, that is, 
once they have been exposed to capacitating conditions and are faced with the task of 
navigating the oviduct and penetrating egg vestments. Indeed, the signalling pathways 
involved in generating ‘activated’ versus ‘hyperactivated’ motility (discussed in detail in 
Chapter 1) are distinct.  
 
Whilst a basic semen analysis is the cornerstone of male fertility investigations, and is 
adept at identifying men whose chances of fertilising oocytes is very low, for example those 
with severe oligo-, astheno-, or teratozoospermia, with respect to the majority of cases, 
semen analysis does not have the power to unambiguously predict the chances of 
spontaneous conception, or indeed success with a particular form of assisted reproduction 
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(Tomlinson et al., 1999). Even when confounding female factors are removed, and analyses 
are carried out to a high degree of accuracy, researchers have highlighted the fact that 
there is considerable overlap between the semen parameters of fertile and infertile men 
(Guzick et al., 2001; Jedrzejczak et al., 2008). Moreover, the fact that data gathered by the 
HFEA suggests that up to one quarter of the UK’s subfertile couples are diagnosed with 
‘unexplained’ infertility, it seems entirely plausible that unidentified or ‘hidden’ male factor 
defects could be contributing to this statistic.  
 
2.4 Sperm function testing 
Extended semen analysis and sperm function testing may hold the key to identifying a 
greater number of male factor disorders (Oehninger, 2000). By assessing, either directly or 
indirectly, more sophisticated functional aspects necessary for both passage through the 
female tract and oocyte interaction, a clearer prognosis with respect to a sperm sample’s 
fertilising potential may be achieved. Such methods were developed prior to the 
widespread use of ICSI, in a climate geared towards the examination of sperm defects and 
the determination of their etiology, with a view to finding ways to enhance sperm 
performance.  
 
Particular interest was directed towards gamete interaction, for example, the ability of 
sperm to bind to the zona pellucida or acrosome react (Burkman et al., 1988; Franken et 
al., 1989; Cummins et al., 1991). A meta-analysis of such bioassays demonstrated that their 
predictive power with respect to fertilisation outcome in IVF was indeed high (Oehninger et 
al., 2000).  
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2.5 CASA 
The development of effective computer-assisted sperm analysis, which provided a digital, 
automated means by which to measure cells in real-time, evoked enthusiasm for the study 
of sperm motility characteristics and their influences on fertilising ability. CASA has two 
distinct advantages over manual motility assessment by eye, namely that it can determine 
cell velocity with a high degree of accuracy and that it can assess literally hundreds of cells 
in a matter of seconds. Whilst some studies have indicated that CASA may be as reliable as 
manual methods for carrying out some aspects of semen analysis (Tomlinson et al., 2011), 
its key strength lies in its ability to measure extremely subtle kinematic parameters, for 
example straightness of  sperm swimming and lateral displacement of the sperm head. 
Obtaining numerical values for these would be impossible to accomplish by eye, and highly 
time consuming using laborious older methods such as videomicrography combined with 
manual trajectory reconstruction (Mortimer, 1997).  
 
CASA with negative phase contrast optics identifies human sperm in a field of view based 
on settings pertaining to their size and illumination (Mortimer, 1997). By tracking each 
sperm head and reconstructing its trajectory, a wealth of mathematical information can be 
gained regarding particular aspects of sperm motion. Using the centroid (the centremost 
point of the head) as a reference point, the primary kinematic values determined are those 
of three distinct velocities (Figure 2.1). Each refers to the distance travelled in within a set 
time period, and is therefore a direct reflection of velocity. The curvilinear velocity (VCL) is 
a measure of the overall distance travelled in any direction. It is dependent on the 
frequency of tail beating, and the wavelength and amplitude of the flagellar movement 
(Suarez and Dai, 1992). The straight-line velocity (VSL) is the distance between the start and 
end of the sperm trajectory, and it therefore describes the distance covered in a straight 
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line. Average path velocity (VAP) is the length of the general trajectory, that is, the distance 
the sperm travels in the average direction of its movement. It is calculated by the CASA 
using sophisticated ‘smoothing’ methods. 
      
 
Figure 2.1: Kinematic parameters measured by CASA. Schematic showing a digitally 
reconstructed sperm trajectory and the kinematic values recorded. From (Oehninger and 
Kruger, 2007).   
 
From these velocities, additional numerical values have been derived, namely, linearity 
(LIN), which equals (VSL/VCL) x 100, and straightness (STR), which is (VSL/VAP) x 100. These 
provide comparative information regarding the different paths observed, allowing greater 
distinction between the types of motility, be it progressive or otherwise.  
 
The amplitude of lateral head displacement (ALH) measures the width the sperm head 
moves from side to side, and to an extent corresponds to the degree of bending initiated at 
the sperm neck (Oehninger and Kruger, 2007). Calculations of its value are based upon the 
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distance between the peaks and the troughs of the centroid’s path, and often this value is 
expressed as the mean of a series of values measured all along the trajectory 
(HamiltonThorne). The derivation of beat/cross frequency (BCF) works on the assumption 
that with each new flagellar beat the curvilinear path will cross the average path, and this is 
how it is calculated (Mortimer, 1997). 
    
2.6 Assessment of hyperactivation using CASA 
CASA has enabled the direct assessment of hyperactivation levels in a sperm sample, which 
doing by eye would be uncontrolled, subjective, and extremely difficult. Hyperactivation is 
of course a flagellar phenomenon, but the waves themselves are extremely difficult to 
measure due to the frequency and subtleties of their movement. A highly time-consuming 
process, only a relatively low proportion of sperm can be analysed (Suarez, 2008). 
Therefore, CASA systems track the sperm head. Whilst this is only an indirect measurement 
of the tail movement, it has been validated as a satisfactory method of hyperactivated cell 
identification (Mortimer, 1997).  
 
 The transition to hyperactivated movement in human sperm involves an increase in overall 
cell speed combined with more pronounced, asymmetric, flagellar bending. These changes 
are directly reflected in sperm trajectories; VCL and ALH increase, whilst LIN 
correspondingly is reduced. Algorithms used to define a hyperactivated cell are 
conventionally based around threshold values for VCL, ALH and LIN levels, allowing the 
specific isolation of cells comprising meeting requirements for all three. It can then be 
established what proportion of the total number of cells are moving in this manner (i.e. the 
% hyperactivation). This has been found to be a more appropriate measure of the degree 
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of hyperactivation in a sample than using population averaged values for VCL, ALH and LIN 
(ESHRE, 1996).    
 
2.7 CASA hyperactivation screens for clinical use 
Numerous investigators have attempted to address whether or not CASA measurements of 
kinematic parameters in semen could be useful in providing prospective indications 
regarding sperm fertilising capacity, both in vivo and in vitro, with some yielding 
encouraging results (Barratt et al., 1993; Paston et al., 1994; Macleod and Irvine, 1995; 
Lefievre et al., 2009) Moreover, the expression of hyperactivation in an appropriate 
medium, a parameter which could not be assessed using routine andrology diagnostics, yet 
which had potential clinical significance, became a particular focus of investigation 
(Sukcharoen et al., 1995; Sukcharoen et al., 1995; Chan et al., 1998). 
 
Intriguing results emerged from clinical studies of hyperactivation under IVF conditions. IVF 
using conventional insemination presents an ideal system with which to measure the effect 
of this movement pattern on overall sperm function. Whilst the female reproductive tract 
is discounted, the zona and cumulus (passage through which is, arguably, the primary 
requirement of hyperactivation) remain. By using fertilisation as an end point with which to 
judge sperm competence, instead of, for example, pregnancy in vivo, an in vitro scenario is 
influenced by fewer variables and confounding factors. Investigators reported correlations 
between hyperactivation rate and fertilisation rate, and degrees of positive and negative 
predictive power (Wang et al., 1993; Guerin et al., 1995; Sukcharoen et al., 1995; Chan et 
al., 1998). Interestingly, one study even went so far as to use in vitro fertilisation outcome 
as the functional end point by which to define the criteria that best identified a 
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hyperactivated subpopulation of cells (Sukcharoen et al., 1995), suggesting that 
hyperactivation was a truly critical functional parameter which should not be ignored.  
 
2.8 Problems surrounding assay development 
Whilst evidence suggested that not only did hyperactivation-specific pathologies exist, but 
that their identification may be important in clinical decision making, a lack of 
standardised, uniform criteria for its measurement produced results which were essentially 
non-transferrable to other laboratories (Oehninger et al., 2000).  
 
For example, significant confusion surrounded which specific movement characteristics (as 
quantified by CASA) actually denoted a hyperactivated cell, and no consensus was 
established on this. Different authors proposed, and utilised, different algorithms for this 
task (Robertson et al., 1988; Grunert et al., 1990; Mortimer and Mortimer, 1990; Burkman, 
1991; Zhu et al., 1994; Sukcharoen et al., 1995). The result of this was that particular 
algorithms may have held value within the context of the setting in which they were 
developed, but were not necessarily translational to other laboratories (ESHRE, 1996). As 
well as differences in opinion as to what type of movement specifically constituted 
hyperactivation, discrepancies between makes and models of CASAs, which operated using 
different frame rates and therefore did reconstruct like for like trajectories, served to 
further compound this problem (Zhu et al., 1994). Disparities in sperm preparation 
techniques, media constituency and slide chamber depths also contributed to the 
generation of inconsistent, non-transferrable results (ESHRE, 1996; ESHRE, 1998).  
 
Perhaps an even greater problem than the technical aspects posed by the measurement of 
hyperactivation, is the manner in which hyperactivation is actually displayed. For example, 
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human sperm populations differ from that of other animals in that only a relatively small 
proportion of cells display natural hyperactivation at any one time, that is, approximately 
20% (Burkman, 1984). Distinguishing between ‘low ‘ and ‘high’ hyperactivation levels is 
therefore difficult, and the opportunity for error if insufficient sperm are counted (i.e. only 
100) is large (WHO, 1999), a detail some previous studies failed to acknowledge.  
 
The expression of spontaneous hyperactivation has also been observed to vary over time 
(Sukcharoen et al., 1995; Chan et al., 1998), rendering it difficult to judge when exactly to 
conduct a CASA assessment and reliably evaluate hyperactivation. Furthermore, 
hyperactivated movement has been described by observers as ‘biphasic,’ meaning that 
cells can switch in and out of hyperactivation over a period of a few seconds and 
apparently at random (Mortimer and Swan, 1995). Indeed this behaviour is thought to be 
exaggerated in vitro (Suarez, 1996; Pacey et al., 1997).  
 
2.9  Assay development and modification 
Many of these historical problems can now be addressed, however, and with appropriate 
use of equipment and technique optimisation it seems possible that hyperactivation assays 
have the potential to deliver reproducible and reliable results. For example, whilst in ideal 
circumstances, independent validation of algorithms used to denote a hyperactivated cell 
(using either visual methods or flagellar analysis) should be employed for each machine, 
ensuring the use of criteria previously validated for an identical sampling frequency and 
smoothing algorithm is likely to be sufficient to generate consistent results (Mortimer, 
1997). In addition, the adherence to guidelines regarding CASA use would also help to 
improve and standardise results (ESHRE, 1998). Such guidelines recommend the use of only 
sperm preparation techniques which produce no deleterious effects on sperm function 
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(Mortimer, 1994), the use of a defined culture medium which does not enhance the 
generation of reactive oxygen species (Gomez and Aitken, 1996) and a slide chamber deep 
enough to permit sufficient flagellar excursion.   
 
Stimulants known to elicit enhance hyperactivation, such as progesterone or pentoxifylline 
(Mbizvo et al., 1993; Johnston et al., 1994; Fabbri et al., 1998) may enable better 
synchronisation of sperm populations. In theory what they measure is the full potential of 
cells to hyperactivate, rather than just their hyperactivation levels at one specific time 
point. Speculatively, this modification may both solve the problem of when to conduct a 
hyperactivation assay and/or go some way to counteract biphasic expression. One assay 
format involved a one hour pre-incubation of sperm samples with progesterone plus 
pentoxfylline. This assay demonstrated, quite impressively, 100% specificity and sensitivity 
in distinguishing poor (0-49%) from good (50-100%) fertilisation rates, however the sample 
size was small at only 29 cases (Bjorndahl et al., 2010). The heating of sperm to 40
o
C 
degrees has also been shown to enhance hyperactivation, and the ability to induce 
hyperactivation in response to heating linked to fertility potential (Chan et al., 1998).  
 
2.10 Development of a hyperactivation assay in the current era of assisted reproduction 
Most of the investigative work into the clinical significance of hyperactivation was 
conducted in the early to mid 1990’s, that is, before guidelines for obtaining accurate and 
transferrable results were laid down. The widespread use of ICSI thereafter prompted a 
decline in sperm function research, and the true potential of a hyperactivation screen was 
never really elucidated. However, a number of recent developments justify further 
exploration of the clinical significance of hyperactivation in human sperm; not least of 
which is the fact that animal studies have its fundamental biological role in fertilisation in a 
42 
 
number of species (Stauss et al., 1995; Qi et al., 2007; McPartlin et al., 2009). The 
expression of hyperactivation by human sperm has also been clearly liked to other aspects 
of sperm function. For example, a positive correlation has been noted between the 
expression of hyperactivated motility in human sperm and the zona pellucida-induced 
acrosome reaction of zona-bound sperm (Liu et al., 2007). With respect to sperm 
morphology, cells displaying hyperactivated motility under appropriate measurement 
conditions had a highly significantly increased chance of being morphologically normal than 
cells not exhibiting this movement pattern (Green and Fishel, 1999). Experiments assessing 
sperm chromatin have also linked the presence of high DNA damage with low levels of 
hyperactivation (Chan et al., 2001). As the integrity of the paternal genome is proposed not 
only to impact on the incidence of fertilisation, but also to exert ‘late’ effects on embryo 
development (Teves et al., 2006), there are significant negative implications associated 
with increased DNA fragmentation. All of these findings imply that the assessment of a 
sperm sample’s ability to promote hyperactivation may not simply provide information 
about its mechanical capabilities in terms of penetration of the barriers posed by the latter 
part of the female reproductive tract and egg vestments, but that it may also serve as a 
biomarker by which to identify and an all-round good quality sample. 
 
There exists also the potential to trial an entirely novel agonist in a hyperactivation assay. 
The ability of 4-AP to induce a dramatic increase in hyperactivation, which persists until the 
drug is removed (Gu et al., 2004), may render it a more effective stimulant than those 
favoured previously. Once a reliable protocol was established, an assay of hyperactivation 
using 4-AP could be carried out very simply and quickly, in contrast to other tests of sperm 
function which involve more laborious procedures and the use of scarce biological material 
(Burkman et al., 1988; Franken et al., 1989). 
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The Assisted Conception Unit within Ninewells Hospital, Dundee, presents an excellent 
opportunity in which to study hyperactivation in the context of a clinical setting. With a 
relatively conservative use of ICSI (employed in less than 40% of all inseminations) and 
active patient recruitment for research, the clinic yields a number of ‘surplus’ samples from 
conventional IVF each week. By comparing hyperactivation levels in a sperm sample with 
its potential to fertilise oocytes in IVF, it may be possible to establish whether or not a 
hyperactivation screen has any merit as a prognostic tool in the current era of ART.   
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Chapter 3: Aims and objectives 
A series of experiments were designed and carried out in order to accomplish four primary 
objectives, outlined below.  
  
1. Selection of an agonist for use in a hyperactivation assay. 
2. Exploration of the link between hyperactivation and subfertility. 
3. Conduction of a study comparing IVF fertilisation outcome with hyperactivation 
levels.   
4. Examination of the effects on hyperactivation of pharmacological agents known to 
interact with store-operated calcium signalling pathways.            
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Chapter 4: Experimental procedures 
4.1 Media and reagents 
 Four different culture media were used across the experimental chapters. Clinical samples, 
and donor samples used for comparable analysis with clinical samples, were tested in Cook 
Medical Sperm Medium™ (capacitating, bicarbonate buffered) for IVF, and Cook Medical 
Gamete Buffer™ (non-capacitating, HEPES buffered) for ICSI. Experiments not involving 
clinical samples were conducted using laboratory synthesised corresponding media, for 
economic purposes (Tables 4.1 and 4.2). The components used were very similar to the 
commercial media, but HSA was replaced with BSA.  
  
Capacitating Medium (CM) 
Component Sigma Cat. No Final Concentration in dH2O (mM) 
CaCl2 C3306 3 
KCl P5405 4.7 
MgSO4, 7H2O M2773 1 
NaCl S5886 106 
NaHCO3 S5761 25 
NaH2PO4 S5012 1.5 
D-glucose G6152 5.6 
Na pyruvate P2256 1 
Sodium lactate L7900 41.8 
Glycine G7403 1.33 
Glutamine G3126 0.68 
Taurine T0625 0.07 
Non-essential amino acids M7145 0.01 
BSA A9418 30mg/ml 
Table 4.1: Recipe for Capacitating Medium. CM was made up once per month from stock 
solutions and deionised H2O. pH was adjusted to 7.4 using 1M NaOH, and osmolarity to 
290-320 mOsm using NaCl. BSA was added only immediately prior to use media use, i.e. 
30mg/ml each day. To eradicate microorganisms, media was then filtered using a 0.22µm 
diameter filter, and stored at 5
o
C. Adapted from (Mortimer, 1986). 
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Non-capacitating Buffer (NCB) 
Component Sigma Cat. No Final Concentration in dH2O (mM) 
CaCl2 C3306 1.8 
KCl P5405 5.4 
MgSO4, 7H2O M2773 0.8 
NaCl S5886 116.4 
NaH2PO4 S5012 1 
D-glucose G6152 5.6 
Na pyruvate P2256 2.7 
Sodium lactate L7900 41.75 
HEPES H3375 25 
BSA A9418 3mg/ml 
Table 4.2: Non-capacitating Buffer. NCB was made up once per month from stock solutions 
and deionised H2O. pH was adjusted to 7.4 using 1M NaOH, and osmolarity to 290-320 
mOsm using NaCl. BSA was added only immediately prior to use media use, i.e. 3mg/ml 
each day. To eradicate microorganisms, media was then filtered using a 0.22µm diameter 
filter, and stored at 5
o
C. 
 
The pharmacological agents used in attempt to modify the expression of hyperactivation 
are detailed in Table 4.3. 
 
Agent Formula Supplier Catalogue no. 
Progesterone C21H30O2 Sigma P0130 
4-aminopyridine (4-AP) C5H6N2 Sigma 275875 
3-Isobutyl-1-methylxanthine (IBMX) C10H14N4O2 Sigma I7018 
2-Aminoethoxydiphenylborate (2-ABP) C14H16BNO Calbiochem 100065 
SKF-96365, Hydrochloride (SKF-96365) C22H26N2O3 . HCl Calbiochem 567310 
Table 4.3: Agents applied to sperm in an attempt to modify hyperactivation. 
 
4.2 Procurement of sperm samples  
Sperm samples were sourced both from a panel of research donors and from men 
attending the Assisted Conception Unit at Ninewells Hospital, Dundee, for IVF or ICSI. 
Patients undergoing IVF or ICSI with their partners were invited to participate in research 
by donating sperm samples that were surplus following oocyte insemination. Ethical 
approval was secured (Tayside Committee of Medical Research Ethics B, number 
09/s1402/6), and informed consent was provided by everyone who took part (consent 
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form shown in section 10.2). Research donors were recruited and consented in accordance 
with HFEA regulations governing the donation of sperm for research.  
 
4.3  Sample collection 
Patient semen samples were produced by masturbation, following two to five days of 
sexual abstinence, on the day of their partner’s oocyte retrieval. The ejaculates were 
subsequently placed a in 37
o
C warming oven until full liquefaction was achieved, with 
processing commencing no later than one hour post production. Research donors were 
instructed to produce their samples in their home and then deliver them to the laboratory, 
whilst keeping them warm, within one hour. Upon arrival, sample processing began 
immediately.  
 
4.4 Semen analysis 
In the Assisted Conception Unit, semen analysis was performed manually by an 
embryologist. Concentration was determined using the dilution method and an Improved 
Neubauer Chamber. Motility was assessed at 37
o
C, and grading was carried out using the A, 
B, C, D scoring system, detailed in (Bjorndahl et al., 2010). Morphology assessment and an 
IgG MAR test for anti-sperm antibodies were conducted at a prior diagnostic appointment. 
Sample parameters were compared against criteria from (WHO, 1999) for normal limits, 
that is, concentration ≥ 20M/ml, motility ≥ 50% and morphology ≥15%. If semen analysis 
yielded a ‘normal’ result or pointed to a mild male factor component, then samples were 
scheduled for IVF. Indications for ICSI were analyses showing moderate to severe male 
factor components, the presence of clinically significant anti-sperm antibody binding, or a 
post-preparation recovery showing less than 1 million progressively motile sperm, less than 
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80% progressively motile sperm, or predominantly sluggish progressive motility. ICSI would 
also be favoured had a previous cycle resulted in a very poor fertilisation rate of MII eggs.  
 
Research donor semen was analysed using CASA for concentration and motility. Sperm 
morphology and anti-sperm antibodies were not assessed. Donor samples were only 
included if they met WHO criteria for ‘normal’ semen in terms of concentration and 
motility (WHO, 1999). Semen samples with a round cell concentration of over 5M/ml were 
excluded from the study.  
 
4.5 Sperm preparation 
Clinical samples from men undergoing IVF or ICSI were prepared in the embryology 
laboratory using discontinuous density gradient centrifugation followed by a simple wash 
step. Briefly, 1ml of room temperature 80% Pure Sperm™ in HEPES-based Gamete Buffer™ 
was overlaid with 1ml of the corresponding 40% fraction, with care being taken to ensure 
that a clear interface was obtained. Up to 2.5ml of semen was then layered on top of this, 
with ejaculates greater than 2.5ml being distributed between two gradients. The gradient 
tubes were centrifuged for 20 minutes at 300xg. Following removal of all supernatant 
layers, pellets were then extracted and washed for 10 minutes at 500xg, either in 5ml Cook 
Sperm Medium™ (if IVF) or 5ml Cook Gamete Buffer™ (if ICSI). The final pellet/s was then 
resuspended in 1ml of the appropriate medium. ICSI samples in HEPES-based Gamete 
Buffer™ were stored at room temperature on the bench for approximately five to six hours 
until insemination. IVF samples in bicarbonate-buffered Sperm Medium™ were ‘gassed’ 
with CO2 and stored at room temperature for approximately four to five hours, before 
being incubated for one hour at 37
o
C and 6% CO2 prior to insemination. An identical 
protocol was followed in the research laboratory for the processing of research donor 
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sperm, which was prepared in either Sperm Medium™ or Gamete Buffer™ depending on 
whether the sample was being compared with IVF or ICSI sperm. Procedurally, the only 
difference in handling of the research laboratory samples was that these were sometimes 
screened earlier than six hours post production; however, this was validated as an 
acceptable alteration (see Chapter 10.1). 
 
4.6 Assessment of hyperactivation using CASA 
A Hamilton Thorne ‘CEROS’ Computer Assisted Sperm Analyser was used for the 
assessment of sperm kinematics in all experiments of this nature. With negative phase 
contrast trinocular optics and a black and white CCD camera, this model was combined 
with Version 12 software, specifically the clinical (human) application. 
 
The settings used in the screening program were kept constant, and are shown in Table 4.4. 
Setting Value 
Magnification 10x objective (100x overall magnification) 
Slide chamber depth 20microns 
Frame rate 60 Hz 
Number of frames recorded 30 
Table 4.4: CASA settings.  
 
A Hamilton Thorne 2X-CEL (20µm depth) microscope slide plus cover slip were pre-warmed 
for two minutes on a MiniTherm heated stage mounted on the CASA microscope. It was 
noted that recommendations designate the use of a 30µm chamber depth for the 
measurement of hyperactivation, to avoid any constraint in flagellar bending, however 
these were unavailable. In any case, the fact that many samples were still able to generate 
very high levels of hyperactivation suggests that this was unlikely to be a particularly 
limiting or distorting factor. Sample concentration was adjusted to 10-20 M/ml, and the 
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sample aspirated gently to ensure homogenous distribution of cells.  4µl of this sample was 
then pipetted onto each slide chamber of the pre-warmed slide, and covered carefully with 
the pre-warmed cover slip (see Chapter 10.1). CASA scanning was delayed for 30s to ensure 
full equilibration of sperm to 37
o
C, and the cessation of any ‘drift.’ To obtain representative 
measurement a total of 800 motile cells were assessed (see Chapter 10.1). This was 
accomplished by scanning at least four microscope fields (at approximately 15M/ml this 
equates about 200 cells) in four slide chambers (Figure 4.1). The playback feature was used 
routinely to ensure that the majority of sperm cells were picked up, and that drift and the 
presence of round cells or debris were not biasing scan results. Where sperm were seen to 
be omitted from the analysis or round cells or debris seen to be included, the interactive 
quality control plot feature was used to readjust the size and intensity parameters used to 
define a sperm head in an attempt to capture as many sperm as possible. Once four lines of 
data, each comprising at least 200 motile cells, were obtained then the slide was removed 
from the heated stage and either washed (a maximum of four times altogether) or 
discarded. Tables 4.5 and 4.6 detail the motility parameters measured and recorded for 
each screen. Data was transferred from CASA to a specifically designed Excel sheet, and 
manipulated from there.    
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Slide 1 
 
 
 
 
 
 
 
 
Slide 2 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Method used for scanning microscope fields. Protocol was designed in an 
attempt to avoid bias introduced by ‘problem’ slide chambers. 
 
Cell counts (number and/or %) plus concentration (M/ml) 
Total 
Motile (rapid plus medium) 
Progressively motile (VAP  25 µm plus STR ≥ 80) 
Rapid (VAP  25µm/s) 
Medium (VAP 5-25µm/s) 
Slow (VAP < 5µm/s plus VSL < 11 µm/s) 
Static (immotile) 
Hyperactivated* (VCL ≥ 150µm/s, ALH ≥ 7µm, LIN ≤ 50, ≥ 13 track points available (from 
possible 30)) 
Table 4.5: Classification of cells by CASA. *Algorithm validated for frame rate in (Mortimer 
et al., 1998). Note: despite having a high VCL, hyperactivated cells moving on the spot (e.g. 
star spin) are often classified as ‘slow’ cells. Percentage hyperactivation was defined as the 
number of hyperactivated cells divided by the total number of motile cells.    
 
Means plus bar chart distributions Units 
VAP µm/s 
VCL µm/s 
VSL µm/s 
ALH µm 
BCF Hz 
LIN VSL/VCL 
STR VSL/VAP 
Table 4.6: Kinematic parameters recorded by CASA. 
 
  
 
  
200 motile cells 200 motile cells 
200 motile cells 200 motile cells 
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Chapter 5: Selection of an agonist for use in a hyperactivation assay 
5.1 Introduction 
Support of capacitation and hyperactivation requires the suspension of sperm in fluids from 
the oviduct or a synthetic medium designed to mimic this environment (De Jonge, 2005). 
Hyperactivation is further enhanced by agents known to specifically promote its 
expression. Both compounds present in the female reproductive tract, such as 
progesterone and nitric oxide (Publicover et al., 2007; Lefievre et al., 2009), and a range of 
non-endogenous agents, can elicit hyperactivation in vitro for the purpose of analysis. 
Published work on hyperactivation stimulants indicate that these can be broadly divided 
into two categories: those that cause an elevation of intracellular calcium ion levels and 
those that influence the AC-cAMP-PKA pathway.  
 
In mammals, examples of reagents which directly affect [Ca
2+
]i include calcium ionophores 
(Suarez et al., 1987), procaine, caffeine (Marquez and Suarez, 2004), thimerosal and 
thapsigargin (Ho and Suarez, 2001), 4-aminopyridine (Gu et al., 2004; Chang and Suarez, 
2011) and progesterone (Publicover et al., 2007). The immediate elevation of cytosolic 
calcium ion concentration has been shown to correspond with an increase in flagellar bend 
and asymmetry (Blackmore et al., 1990; Baldi et al., 1991; Bedu-Addo et al., 2007; 
Gakamsky et al., 2009; Kilic et al., 2009; Lishko et al., 2011; Strunker et al., 2011). 
  
The primary stimulant of hyperactivation in vivo appears to be progesterone, and indeed 
this modification of motility appears to be the primary action of this steroid on sperm cells 
(Aitken et al., 1996; Publicover et al., 2007; Bedu-Addo et al., 2008). Progesterone at nM-
µM concentrations can also induce the acrosome reaction, and the ability of sperm to raise 
intracellular calcium ion levels in response to progesterone has been linked with 
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fertilisation potential in humans (Krausz et al., 1995; Krausz et al., 1996; Forti et al., 1999; 
Giojalas et al., 2004). As sperm are thought to be transcriptionally inert, in these cells the 
steroid hormone progesterone acts through a ‘non-genomic’ pathway (Strunker et al., 
2011). The response to bolus doses of µM progesterone is composed of a biphasic signal; 
an initial Ca
2+
 transient, which peaks within the 30s following dosage, is followed by a ‘late’ 
plateau component which persists for longer than twenty minutes (Figure 5.1) (Blackmore 
et al., 1990; Kirkman-Brown et al., 2000; Strunker et al., 2011).  
 
 
Figure 5.1: Patterns of intracellular Ca
2+
 in response to 3.2µM progesterone. From 
(Kirkman-Brown et al., 2003). The traces represent the Ca
2+
 signals obtained from 23 donor 
sperm samples, as measured using fluorimetric measurement of Calcium Green 1-AM. The 
arrow represents the point at which progesterone was applied.   
  
The transient has been attributed to Ca
2+
 influx via CatSper channels, which have recently 
been revealed as a direct target of progesterone in human sperm (Lishko et al., 2011; 
Strunker et al., 2011). However, even when extracellular calcium ions are unavailable, a 
response to progesterone is still apparent (Bedu-Addo et al., 2007), suggesting that 
progesterone activates two discrete Ca
2+
 signalling responses in human sperm.  
 
4-Aminopyridine, in its membrane-permeable form, is a highly potent inducer of 
hyperactivation in human sperm, modulating flagellar bending dramatically, even in 
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uncapacitated cells. This effect can be observed instantly, and persists until the drug is 
removed (Gu et al., 2004; Barfield et al., 2005; Bedu-Addo et al., 2008). Particularly active 
at a concentration of 2mM, single-cell imaging experiments revealed a parallel sustained 
rise in Ca
2+
 in the vicinity of the sperm neck/midpiece (Figure 5.2) .  
 
 
Figure 5.2: Patterns of intracellular Ca2+ in response to 2mM 4-AP. From (Costello, 2010-
2011). The traces show the 4-AP-induced increase in fluorescence of Oregon-Green BAPTA-
1 (representing the increase in [Ca
2+
]i).   
 
A well known blocker of voltage-gated K
+
 channels (Barfield et al., 2005), the elevation of 
[Ca
2+
]i appears to occur independently of this action, as responses are resistant to 
‘clamping’ of the cell membrane potential with valinomycin (Bedu-Addo et al., 2008). 4-AP 
is also a weak base, and thereby promotes intracellular alkalinisation. As CatSper current is 
alkaline dependent (Navarro et al., 2007), it could be proposed that this action of 4-AP was 
responsible for the ensuing rise in Ca
2+
. However, the addition of 25mM NHCl, to raise 
intracellular pH to the same degree as 4-AP, did not preclude a further Ca
2+
 response to 4-
AP, suggesting that the potentiation of CatSper was not the main action of the drug 
(Costello, 2010-2011).  
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It appears that 4-AP, like progesterone, mobilises stored Ca
2+
 by some mechanism which is 
yet to be fully elucidated. When calcium ions were omitted from the medium in which the 
sperm were suspended, i.e. the extracellular concentration was very low at 5µM, a Ca
2+
 
response was still observed in 75% of cells. Whilst prolonged incubation with EGTA 
abolished the response altogether, when 4-AP was applied after only a few minutes then a 
small, transient response could still be noted in 25% of cells (Bedu-Addo et al., 2008). 4-AP 
does not induce the acrosome reaction in human sperm cells, which reinforces the concept 
that sperm regulates Ca
2+
 mediated cellular activities using discrete, hard wired responses 
(Bedu-Addo et al., 2008).   
 
Whilst store mobilisation alone, by either progesterone or 4-AP, may not provide enough 
Ca
2+
 ions to significantly impact on any Ca
2+
-mediated flagellar response, it has been 
proposed that capacitative calcium entry or store-operated calcium entry (CCE and SOCE 
respectively) may be responsible for translating store mobilisation into a significant rise in 
calcium ion concentration around the base of the flagellum (discussed in Chapter 8).  
 
Activators of adenylate cyclase, such as 2’-deoxyadenosine, have a stimulatory effect on 
sperm motility (Moohan et al., 1995). Phosphodiesterase inhibitors, such as pentoxyfilline 
and IBMX, restrict the breakdown of intracellular cAMP, thereby exerting their effect 
downstream on the same pathway, resulting in a similar positive effect on sperm 
movement (Jiang et al., 1984; Tesarik et al., 1992; Tournaye et al., 1994; Calogero et al., 
1998; Fisch et al., 1998; Nassar et al., 1998).  
 
It is unclear to what degree the downstream effects on motility produced by cAMP and Ca
2+
 
are shared. One may activate the other, for example cAMP will open nucleotide-gated Ca
2+
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channels (De Jonge and Barratt, 2006), and the target of calcium ions, that is calmodulin, 
can also influence enzymes that result in the production of cAMP (Oehninger and Kruger, 
2007). However, both in humans and other mammals, their actions on the axoneme and 
motility have been shown to be distinct. Experiments in bull sperm revealed that, whilst 
essential for the induction of capacitation and the activation of motility, the AC/cAMP/PKA 
signalling pathway did not influence hyperactivation specifically. Only those agents 
affecting intracellular calcium ion levels directly contributed to hyperactivation. 
Furthermore, their effects were not due to any tyrosine phosphorylation, suggesting that 
calmodulin must have other flagellar targets (Marquez and Suarez, 2004; Marquez and 
Suarez, 2008). In humans, a study in which sperm were capacitated and hyperactivated by 
suspending them in a commercial IVF medium, showed that neither of these effects were 
controlled by PKA, although tyrosine phosphorylation did increase with these events in this 
case (Moseley et al., 2005). However, these results are contradictory to those of other 
studies which have documented a specific influence on the kinematic parameters which 
define hyperactivation (that is VCL, ALH and LIN) by phosphodiesterase inhibitors (Kay et 
al., 1993). 
  
In order to be feasible for routine clinical application, a hyperactivation assay would have 
to be able to elicit maximal hyperactivation very quickly. In order to establish whether or 
not this could be accomplished using the agonists discussed above, that is, progetsreone, 
IBMX and 4-AP, each was monitored for its efficacy. Influences on motility were studied 
with respect to both the degree to which they modulated VCL, ALH and LIN and 
hyperactivation, and the proportion of cells in which they were effective.   
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5.2 Experimental procedures 
Sperm samples for this chapter were sourced from research donors whose ejaculates were 
considered ‘normal’ according to WHO criteria (WHO, 1999). Sperm preparation methods 
and the assessment of hyperactivation using CASA are detailed in Chapter 4. Cells were 
resuspended in CM for testing, the recipe for which is also presented Chapter 4. Briefly, 
prepared samples were divided into four aliquots: control, progesterone, IBMX and 4-AP. 
Each reagent was applied to samples only immediately prior to CASA assessment, and 
aspirated four or five times before loading onto the microscope slide to ensure 
homogenous distribution of both the drug and the cells. Final concentrations were: 3.6µM 
for progesterone, 100µM for IBMX and 2mM for 4-AP. 
 
5.3 Statistics 
As all data obtained for VCL, ALH, LIN and % hyperactivation were found to be 
approximately normally distributed (using the Kolmorogov-Smirnoff test) and of 
approximately homogenous variance (F-test), differences between samples were analysed 
using the Paired sample t-test. Mean percentage increase in hyperactivation was a 
parameter which showed significant heterogeneity of variance amongst the progesterone, 
IBMX and 4-AP treated groups, therefore the Wilcoxon signed-ranks test was used to 
examine differences in these cases. All statistical tests were carried out in SPSS version 17.   
    
5.4 Results 
 
The effects of 3.6µM progesterone, 100µM IBMX and 2mM 4-AP on the individual motion 
parameters that comprise the algorithm for hyperactivation, that is VCL, ALH and LIN, and 
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hyperactivation itself, are detailed in Table 5.1. All three reagents significantly increased 
VCL and ALH. Progesterone and 4-AP, but not IBMX, significantly reduced LIN.  
 
IBMX exerted the largest effect on VCL. This was significantly different to that of the 
progesterone induced response (P=0.000), but not different to that of 4-AP (P=0.476). 4-AP 
influenced ALH to the greatest extent, and the mean ALH in the presence of 4-AP was 
significantly higher than the ALH in both the progesterone and IBMX treated samples (P= 
0.022 and P= 0.002 respectively). Similarly, the mean LIN of the 4-AP treated samples was 
significantly lower than it was when either progesterone or IBMX was applied (P= 0.003 
and P= 0 respectively). 
 
Hyperactivation was significantly increased by IBMX and 4-AP, but not by progesterone. 
The mean percentage hyperactivation was highest in the samples treated with 4-AP, and 
although this value was significantly different to the progesterone treated group (P=0.035), 
it was not significantly different to that induced by IBMX (P=0.142). Similarly, the mean 
percentage increase in hyperactivation was not significantly different between the 4-AP 
and IBMX groups (Figure 5.4).  
 
76% of samples responded, in terms of hyperactivation, to IBMX and 4-AP, whilst 
progesterone, the weakest stimulant of hyperactivation under these conditions, only 
promoted an increase in hyperactivation in 59% of samples (Table 5.2). On only one 
occasion did a sample respond to IBMX but not 4-AP, and vice versa. Two samples did not 
exhibit an increase in hyperactivation levels following the application of any of the three 
agents.  
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 VCL (µms
-1
) ALH (µm) LIN (VSL/VCL) x 100 Hyperactivation (%) 
Control 120.1 ± 5.5 4.7 ± 0.3 59.7 ± 2.1 10.1 ± 2.3 
Progesterone 127.1 ± 5 
s
 5.3 ± 0.2 
s
 56 ± 2.1 
s
 12.4 ± 2.4 
IBMX 138.8 ± 5.1 
s
 5.2 ± 0.2 
s
 58 ± 1.9 16 ± 2.7 
s
 
4-AP 136 ± 7.6 
s 
5.8 ± 0.3 
s
 47.7 ± 2 
s
 19.3 ± 3.7 
s
 
Table 5.1: Influences of hyperactivation inducers on individual kinematic parameters. 
Values are mean plus or minus SEM for 17 donor ejaculates. Entries marked with 
s
 indicate 
a significant difference from the control. In terms of hyperactivation specifically, the IBMX 
and 4-AP treated groups were significantly different to the control (P=0.003 and P=0.002 
respectively), whilst progesterone did not induce a significant difference in hyperactivation 
compared to the control (P=0.125). 
 
 
 
 
Figure 5.3: Hyperactivation levels in response to progesterone, IBMX and 4-AP. n= 17 and 
error bars represent mean ±SEM.  
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Figure 5.4: Percentage increase in hyperactivation following treatment with 
progesterone, IBMX and 4-AP. Values represent the mean percentage increase in from the 
control that each stimulant exerted on hyperactivation. n= 17 and error bars represent 
mean ±SEM. The progesterone group is significantly different to the 4-AP and IBMX groups 
(P=0.004 and P=0.19), but they are not significantly different from one another (P=0.301).  
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Sample Control HA 
(%) 
Response to 
Progesterone 
Response to 
IBMX 
Response to 4-
AP 
1 23.5    
2 1.5    
3 7.5    
4 6    
5 1    
6 3    
7 29    
8 10    
9 9    
10 5.5    
11 3    
12 6.5    
13 1    
14 24    
15 10.5    
16 6    
17 30    
Table 5.2: Hyperactivation responses by sample to progesterone, IBMX and 4-AP. The 10
th
 
centiles for the average percentage increase were calculated using only values where the 
treated hyperactivation level was higher than that of the control (i.e. not including any 
negative values). The thresholds were calculated as 9%, for progesterone, 9% for IBXM and 
23% for 4-AP, and anything above these thresholds was considered to be a ‘response.’ Ticks 
show responses, crosses depict the absence of a response.  
          
 
5.5 Discussion 
Progesterone, in comparison to 4-AP and IBMX, was the weakest stimulator of 
hyperactivation under these experimental conditions. Whilst the steroid significantly 
altered each individual motion parameter, that is, VCL, ALH and LIN, this did not translate 
into a significant difference in hyperactivation (Table 5.1). It is possible, however, that a 
larger sample size may have shown this modest increment to be significant.   
 
It could be considered surprising, given the well documented influence of progesterone on 
intracellular calcium ion levels (Blackmore et al., 1990; Baldi et al., 1991; Kirkman-Brown et 
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al., 2003) that the effects of the steroid on hyperactivation under these experimental 
conditions were not more substantial. Previous investigators have documented an ability of 
progesterone to induce hyperactivated motility in human sperm (Uhler et al., 1992; Jaiswal 
et al., 1999), whilst others could not confirm such an action (Kay et al., 1994; Wang et al., 
2001).  
 
A possible explanation as to why progesterone did not promote a significant increase in 
hyperactivation is that the large calcium transient, which typically peaks within one minute 
following the application of a bolus of progesterone at micromolar doses (Kirkman-Brown 
et al., 2000), was ‘missed’ when screening for hyperactivation using the method applied 
here. For example, in the time it took to load a microscope slide, focus the microscope, 
allow any ‘drift’ to stop, and scan a sufficient number of cells, the initial Ca
2+
 transient (and 
corresponding burst of hyperactivation) may have been over. This would mean that only 
the moderate, plateau component of the Ca
2+
 signal was captured by CASA.   
 
Progesterone when presented as a bolus seems to impose on cells some kind of refractory 
period. In vivo, the sperm will not encounter progesterone in this manner; instead, 
secretion of the steroid by the cumulus oophorus should result in the formation of a 
concentration gradient along the length of the oviduct (perhaps even extending into the 
uterus), meaning that sperm in the female tract should encounter progesterone at very low 
doses (nM) initially, followed by progressively larger ones upon approach to the oocyte. 
The reproduction of such a setup in vitro has shown that an altogether different pattern of 
Ca
2+
 signals and hyperactivation are produced under these conditions; a slowly developing 
rise in Ca
2+
, as opposed to a high-amplitude transient, is accompanied by Ca
2+
 oscillations in 
a proportion of cells (Harper et al., 2004). Therefore, the expression of hyperactivation may 
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vary depending on how sperm meet progesterone, and the effects of progesterone on 
hyperactivation in the female are likely to be entirely different to the scenario in vitro.  
 
Moreover, in vivo, sperm are exposed to progesterone in parallel with other stimulatory 
components of the reproductive tract and follicular fluid. For example, in one study, 
follicular fluid induced an increase in hyperactivation, whereas progesterone did not (Wang 
et al., 2001). Nitric oxide in particular has been shown to act synergistically with 
progesterone to enhance and prolong Ca
2+
 signals and corresponding flagellar bending 
(Machado-Oliveira et al., 2008; Lefievre et al., 2009). Therefore, it may be that, in practice, 
the complex effects of progesterone on motility involve too many subtleties to permit the 
generation of a rapid and accurate assay using CASA. 
 
4-AP and IBMX, in contrast, evoked a significant and sustained hyperactivation response 
(Table 5.1). Whilst these agents have no physiological relevance per se, they may offer a 
means by which to interrogate the signalling pathways involved in the control of 
hyperactivation. Both 100µM IBMX and 2mM 4-AP induced a rise in hyperactivation in over 
75% of samples treated (Table 5.2). With regards to IBMX, two of the four samples which 
did not respond to treatment with the drug exhibited already high levels of hyperactivation 
in the control (over 20%), and the same applied in the case of 4-AP.      
 
Whilst both agents therefore appear to be effective activators of hyperactivation, the 
specific kinematics in the 4-AP and IBMX treated samples were not equivalent. For 
example, whilst both drugs significantly raised VCL, only 4-AP acted to significantly reduce 
LIN. In practice, this means that the sperm exposed to IBMX displayed a greater degree of 
space gain and forward movement than those treated with 4-AP. The increased flagellar 
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bending induced by 4-AP (reflected in the high ALH) diminished forward progression; a 
feature that would be particularly prominent when beating was also asymmetrical.  
 
The IBMX group showed a significantly higher BCF than the control group (28.2Hz vs. 
26.8Hz respectively, P= 0.02), indicating that much of the velocity increase here was 
mediated by faster tail beating. In contrast, 4-AP treated sperm samples increased their 
hyperactivation at the expense of beat frequency, which was significantly lower than in the 
control (24.7 vs 26.8, P= 0.001). The increase in velocity in these cells must therefore have 
arisen as a direct result of the force generated by deeper flagellar excursion. Since it is this 
action specifically which is thought to impart the mechanical capabilities necessary for 
passage through viscoelastic substances and the cumulus and zona, and not merely faster 
swimming, it would appear that 4-AP is a more effective inducer of ‘genuine’ 
hyperactivation than is IBMX. Whilst very hyperactivated sperm suspended in low viscosity 
medium produce trajectories which look highly erratic, in a viscous or viscoelastic 
substance these may translate into effective swimming, burrowing and ‘drilling’, actions, as 
may they facilitate direction changes as part of the chemotatic process.      
 
4-AP also produced the highest mean highest and mean percentage increase in 
hyperactivation (Table 5.1, Figure 5.4), rendering the agonist most capable of inducing this 
flagellar phenomenon. Thought to act via its store mobilising ability, 4-AP may also be a 
tool with which to identify men, for the purpose of further analysis, who have problems in 
generating store-mediated Ca
2+
 signals specifically. Indeed, such a pathology has been 
alluded to in a previous study involving asthenozoospermic patients (Espino et al., 2009). 
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Chapter 6: Population-specific expression of hyperactivation  
6.1 Introduction 
Hypeactivation is a parameter which is not routinely measured during basic andrology 
diagnostics, and therefore little has been established regarding the incidence of 
hyperactivation disorders or their prevalence amongst different groups of men. For 
example, it is unclear how closely the ability to induce hyperactivated motility correlates 
with the parameters measured in a semen analysis. It may be, for example, that men 
whose semen characteristics are suboptimal (perhaps, in terms of motility, due to an 
artefact of the semen as opposed to any pathology of the sperm) can readily induce 
hyperactivation, whilst other men who exhibit normal or nearly normal semen 
characteristics (including motility) have difficulty eliciting the more forceful flagellar 
movement that is associated with hyperactivation. By performing only a semen analysis, it 
is possible that an important step in determining a man’s fertility may be omitted.  
 
 Three distinct populations were available in which to probe for any differences in 
hyperactivation between men grouped according to semen analysis and fertility: research 
donors, whose semen parameters were normal yet little was known about their fertility, 
IVF patients, whose semen parameters were normal or approaching normal limits yet who 
formed part of an infertile couple, and ICSI patients, whose semen parameters were 
identified as abnormal or whose sperm had failed to fertilise oocytes during a previous 
cycle of conventional IVF. 4-AP, verified as the most potent inducer of hyperactivation in 
human sperm (Chapter 5), was used as an inducer to elicit maximal levels for the purposes 
of screening.  
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6.2 Experimental procedures   
Sperm samples for this chapter were sourced both from research donors and male patients 
undergoing IVF or ICSI treatment. Methods for selection of donors and allocation of 
patients to standard IVF or ICSI are detailed in Chapter 4, as are sperm preparation 
methods and the assessment of hyperactivation using CASA. All donor sperm samples were 
prepared using clinical media: Cook Sperm Medium™ for those being directly compared 
with IVF samples and Cook Gamete Buffer™ for those being directly compared with ICSI 
samples. The purpose of this was to ensure that the conditions under which patient 
samples were measured were exactly replicated. 4-AP was added immediately prior to 
CASA assessment, at a final concentration of 2mM, and the sample aspirated four or five 
times to ensure homogenous distribution of both the drug and the sperm cells before 
loading onto a microscope slide. All surplus IVF samples donated to research were screened 
for hyperactivation, however, approximately one third of the ICSI samples donated were 
not assessed. Such samples were of very poor quality and it was therefore not possible to 
record 800 motile cells as per the protocol outlined in Chapter 4. 
 
6.3  Statistics  
The Kolmorogov Smirnoff test was used to test for normal distributions. Upon finding that 
two data sets had distributions which were significantly different from a normal 
distribution, for consistency, a non-parametric was used to test for statistically significant 
differences between two groups in all cases. The Mann-Whitney U test was selected 
because all comparisons were between unpaired data, that is, as opposed to between 
repeated measures of the same individuals. All statistical tests were carried out in SPSS 
version 17.   
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6.4 Results  
Table 6.1 summarises the hyperactivation levels observed in each population both in the 
presence and absence of 4-AP. The Mann-Whitney U test returned the result that there 
was no evidence that the hyperactivation levels of the IVF patient group came from a 
different distribution to those of the research donor cohort, i.e. they were not statistically 
different (Figures 6.1 and 6.2). This was the case both when the samples were untreated, 
and when they were tested in the presence of 4-AP. 
 
Conversely, the ICSI patients exhibited significantly lower levels of hyperactivation than 
their research donor counterparts; a difference which was statistically significant in the 
presence of 4-AP-treated and approaching levels of significance without it (Figures 6.3 and 
6.4).  
 
The hyperactivation levels in the IVF patient samples were significantly higher than they 
were in the ICSI population. However, this is not a valid comparison as Cook Sperm 
Medium™ specifically promotes hyperactivation and capacitation, whilst Cook Gamete™ 
Buffer is designed to repress these processes.  
 
With respect to the way in which each population responded to 4-AP, individual values can 
be found in Table 6.2. There were no significant differences between the mean percentage 
response to 4-AP in the IVF patients and the research donors in Cook Sperm Medium™ 
(P=0.77), nor was there any difference between the ICSI patients and the research donors 
in Cook Gamete Buffer™ (P=0.869). In addition, the proportion of ICSI samples which 
responded to 4-AP was similar to the proportion of donor samples which responded (79% 
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vs. 82%). There were no significant differences between the percentage response of 
samples in Gamete Buffer™ and those in Sperm Medium™.  
 
Population No. of 
samples 
Mean % 
hyperactivation 
Std 
deviation 
IVF patient samples untreated 86 8.9 7.6 
IVF patient samples 4-AP 86 18.7 13.3 
Donor samples in Sperm Medium 
untreated 
30 8.6 7.2 
Donor samples in Sperm Medium 
4-AP 
30 15.1 9.4 
ICSI patient samples untreated 24 5.1 6.7 
ICSI patient samples 4-AP 24 10.1 11.7 
Donor samples in Gamete Buffer 
untreated 
22 6.9 6.9 
Donor samples in Gamete Buffer 4-
AP 
22 13.9 10.1 
Table 6.1: Hyperactivation levels in research donors and ART patients. IVF patient samples 
arrived from the Assisted Conception Unit pre-prepared in Cook Sperm Medium™. 
Therefore, in order to ensure that a direct comparison was being made with the research 
donor samples, these were also prepared in this commercial medium. Similarly, any 
research samples being directly compared with ICSI samples were prepared in Cook 
Gamete Buffer ™.  
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Figure 6.1: Hyperactivation in untreated research donor vs. IVF patient sperm samples. All 
measurements were recorded in Cook Sperm Medium™. The interquartile range is 
represented by the box, whilst the line through the box is the median. The whiskers 
correspond with the largest or smallest values within 1.5 interquartile ranges of the edges 
of the box, and the outliers are depicted as dots. The two groups are not significantly 
different (P=0.970). 
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Figure 6.2: Hyperactivation in 4-AP-treated research donor vs.IVF patient sperm samples. 
All measurements were recorded in Cook Sperm Medium™. The interquartile range is 
represented by the box, whilst the line through the box is the median. The whiskers 
correspond with the largest or smallest values within 1.5 interquartile ranges of the edges 
of the box, and the outliers are depicted as dots. The two groups are not significantly 
different (P=0.304). 
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Figure 6.3: Hyperactivation in untreated research donor vs. ICSI patient sperm samples. 
All measurements were recorded in Cook Gamete Buffer™. The interquartile range is 
represented by the box, whilst the line through the box is the median. The whiskers 
correspond with the largest or smallest values within 1.5 interquartile ranges of the edges 
of the box, and the outliers are depicted as dots. The two groups are not significantly 
different (P=0.073). 
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Figure 6.4: Hyperactivation in 4-AP treated research donor vs. ICSI patient sperm 
samples. All measurements were recorded in Cook Gamete Buffer™. The interquartile 
range is represented by the box, whilst the line through the box is the median. The 
whiskers correspond with the largest or smallest values within 1.5 interquartile ranges of 
the edges of the box, and the outliers are depicted as dots. The two groups are statistically 
significantly different (P=0.048). 
 
 Mean % response  to 
4-AP 
Proportion of samples showing 
‘response’ 
IVF patients 211 ± 33 88% 
Donors in Cook Sperm 
Medium 
151 ± 39 77% 
ICSI patients 189 ± 46 79% 
Donors in Cook Gamete 
Buffer 
409 ± 212* 82% 
Table 6.2 Responses to 4-AP in patient and donor sperm. Shown are the mean responses 
(±SEM) of each population to 4-AP, that is, the average percentage increase in 
hypeactivation following the application of 4-AP. Taking an arbitrary value of a 20% 
increase in hyperactivation as a response, the proportion of samples in each group which 
responded to 4-AP is also shown. * Very high SEM means that outlying very high value(s) 
are influencing the overall mean, as the ICSI patients and donors in Gamete Buffer™ are not 
significantly different (P=0.869).  
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6.5 Discussion 
Following treatment with the stimulant 4-AP, the hyperactivation levels displayed by the 
ICSI cohort were significantly lower than those of the research donors, suggesting that 
sperm samples which have been assigned to ICSI exhibit lower levels of hyperactivation 
than samples in which no semen abnormalities have been observed. Similar evidence, 
namely that hyperactivation-specific defects are more prevalent in oligo-, astheno- and 
teratozoospermic patients, has been documented previously (Burkman, 1984; Pilikian et 
al., 1991). It is possible that the reduction in hyperactivation in the ICSI patients was due to 
deficiencies in flagellar architecture, especially, for example, if asthenozoospermia in 
semen was the indication for ICSI in the first place. This could also be attributed to 
inefficient operation of the signalling pathway underlying hyperactivation, however, the 
fact that it was only the absolute values for hyperactivation which were lower, and not the 
ability of these samples to respond to 4-AP suggests that this is less likely. This ability to 
respond was similar to the donor population both in terms of the mean percentage 
response and the number of samples in which a response could be observed, suggesting 
that the signalling pathway exploited by 4-AP at least, is not specifically deficient.  
 
There was no significant difference between hyperactivation in the research donors and 
the IVF patients, even in the presence of 4-AP. Whilst the specific semen analysis results for 
the IVF cohort are not shown, these patients, by virtue of the fact that they were selected 
for IVF as opposed to ICSI in the first place, had normal or nearly normal semen 
characteristics (detailed in Chapter 4). They were, therefore, very similar in this respect to 
the research donor group.   
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The fact that the IVF patients and the research donors were found to be equivalent in 
terms of their ability to induce hyperactivation indicates that the IVF patients are no 
different to ‘normal’ men (with unknown fertility status but who are not being 
investigated/treated for infertility) in this respect. What this means is that there was no 
evidence of any general hyperactivation pathology in the IVF patients which may have been 
responsible for/contributory to their infertility. Certainly the majority of these patients will 
have already had confirmed female factors to specifically account for their infertility.  
 
In conclusion, what these small sample sizes are suggesting is that the expression of 
hyperactivation in a sample is, in a very broad sense, linked to semen characteristics in that 
normal semen samples are more likely to yield sperm which have a good capacity for 
hyperactivation, whereas sperm sourced from abnormal semen samples will be less likely 
to exhibit pronounced hyperactivation. Whilst low levels of hyperactivation are prevalent in 
the ICSI population, any detriment in this respect may be secondary to a far more serious 
sperm defect(s). There has purposely been no attempt made to establish threshold levels 
for ‘normal’ or ‘abnormal’ hyperactivation in this chapter, as without corresponding 
information on fertility, any arbitrary limits set according to, for example, percentile value, 
are essentially meaningless. Whether or not there are any negative clinical outcomes 
associated with samples which exhibit the very lowest levels of hyperactivation, is 
specifically discussed in Chapter 7 which follows.   
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Chapter 7: The value of a pre-IVF hyperactivation screen 
7.1 Introduction 
 
Data gathered in the previous experimental chapter highlighted that the expression of 
hyperactivated motility was linked with semen analysis: samples which were selected for 
ICSI due to a poor semen parameters expressed lower levels of hyperactivation than those 
which were deemed suitable for IVF. What it was unable to do, however, was relate the 
expression of hyperactivation to fertilising potential, and indeed the focus of this chapter is 
to examine the prognostic  potential of a pre-IVF hyperactivation assay. 
 
Using 4-AP, a potent agonist known to promote maximal levels of hyperactivation 
instantaneously (demonstrated in Chapter 5), such an assay could be carried out in 
seconds, on the day of treatment and using the specific ejaculate scheduled for 
insemination, thereby eliminating any discrepancies arising from intra-ejaculate variation.  
 
Importantly, if the experiments carried out in this chapter were to highlight that a 
hyperactivation assay has negative predictive power, then it may have the ability to identify 
samples which, despite a normal or borderline semen analysis, have a poor chance of 
succeeding at IVF. Embryologists regularly redirect treatment from IVF to ICSI if the quality 
of the semen has deteriorated since it was initially tested, and a similar conversion could be 
offered if a sample scored poorly on the hyperactivation test.  
  
Poor or ‘failed’ fertilisation, usually considered less than 25% of oocytes normally fertilised 
(Mortimer and Mortimer, 2004), afflicts approximately 5% of IVF cycles (10% in the 
Assisted Conception Unit at Dundee, not taking into account oocyte maturity). Whilst such 
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events may be interesting from a diagnostic perspective, an entire treatment cycle has 
effectively been wasted. If a hyperactivation screen could help prevent even a small 
number of failed fertilitsations, then it may be worth employing such extended sperm 
testing not only in specialist or research andrology laboratories, but in the IVF laboratory as 
well.  
 
7.2 Experimental procedures 
7.2.1 Patient selection, ovarian stimulation and oocyte recovery  
Patient indications for subfertility/infertility included tubal disease, polycystic ovarian 
syndrome, endometriosis, mild male factor and unexplained. Female patient age ranged 
from 24 to 42, with the mean age being 34.4. Ovarian stimulation was undertaken using 
either the GnRH agonist or antagonist protocol, with gonadotrophin dosage of 150iu/day 
up to 300iu/day depending on the results of any previous stimulation, female age, risk of 
hyperstimulation and BMI. hCG was administered when two follicles reached 18mm or 
greater, and trans-vaginal egg collection was carried out 36 hours later. Cycles which 
yielded fewer than four eggs were excluded from the study, and a mean of 11.4 eggs were 
recovered per cycle. The male patients used in this chapter are the same cohort as the IVF 
patients in Chapter 6.  
  
 7.2.2. Sperm preparation 
The methods for sperm procurement, semen analysis, assignment of samples to IVF or ICSI, 
and sperm preparation are detailed Chapter 4.  
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7.2.3 Insemination  
All eggs, regardless of their maturity status as assessed by the evaluation of the oocyte-
corona-complex, were inseminated at 3:45pm on the day of retrieval, that is, between five 
and seven hours post both egg collection and sperm preparation. Up to 8 oocytes per well 
were inseminated with approximately 150 000 sperm, in a final volume of 0.7ml of Cook 
Fertilisation Medium™ under tissue culture oil. 
 
7.2.4 CASA assessment of hyperactivation 
A detailed protocol for the measurement of hyperactivation can be found in Chapter 4. 
Samples were screened both for spontaneous levels of hyperactivation, and their 
expression of hyperactivation under the influence of 4-AP. 4-AP was chosen as an agonist 
with which to elicit the maximum possible levels of hyperactivation based on the results 
detailed in Chapter 5, which indicate its high potency in human sperm. At a final 
concentration of 2mM, 4-AP was applied to samples only immediately prior to CASA 
assessment, and aspirated four or five times before loading onto the microscope slide to 
ensure homogenous distribution of both the drug and the sperm cells.     
 
7.2.5 Determination of fertilisation rate 
Assigning an appropriate value for fertilisation in the context of this assay was complex; a 
fact which has either been overlooked or inadequately explained by many previous 
investigators. As a marker of quality control in the embryology laboratory, the fertilisation 
rate is conventionally considered to be the number of normally fertilised eggs obtained, 
that is, zygotes displaying two pronuclei, divided by the number total number of eggs 
inseminated (multiplied by one hundred) (Mortimer and Mortimer, 2004). However, since 
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it is only sperm that are being assessed here, it does not seem appropriate to use that 
same definition as an end point.  
 
For example, significant variation in quality between not only each cohort of eggs, but each 
individual egg means that using fertilisation rate as a ‘measure’ of sperm capability is 
essentially uncontrolled. Adjusting for confounding egg factors can alleviate this problem to 
some extent.  
 
Eggs which are immature or very post mature may fail to show signs of fertilisation, even if 
sperm have interacted with the oolemma (Gardner et al., 2004; Elder and Dale, 2011). Such 
eggs should not be included in the total available for fertilisation, as it is impossible to tell 
whether or not the cumulus and zona have been penetrated by sperm. There is also 
evidence to suggest that eggs which are grossly morphologically abnormal, for example 
those containing large vacuoles, are less likely to display signs of fertilisation (Veeck, 1986; 
Gardner et al., 2004; Elder and Dale, 2011). 
  
Using the visualisation of two pronuclei as the only definition of fertilisation seems similarly 
inappropriate when the focus of the assay is sperm competency. For example, 
polypronuclear eggs are not caused by any fault in the sperm, rather the opposite, and 
even eggs displaying a single pronucleus may have been activated by sperm.   
 
Despite the existence of numerous ‘grey areas’ the following tables were created in order 
to provide a methodology with which to classify each oocyte inseminated. Whilst this is 
admittedly an imperfect system, it was nonetheless deemed the best way to assign a 
fertilisation rate to each cycle with respect to putative sperm performance only.   
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Egg status 16 hours 
post-insemination 
Explanation of classification 
Two pronuclei 
present 
Normal fertilisation has taken place 
Three or more 
pronuclei present 
Abnormally fertilised but likely to have been caused by polyspermy 
or non-extrusion of the second polar body 
One pronucleus 
present 
Whilst both parental pronculei should appear simultaneously in a 
normal zygote, evidence suggests that the majority of 1PN’s (up to 
80%) have actually been penetrated by sperm. 
Two polar bodies 
visible 
Whilst it is possible that a polar body may have fragmented, the 
presence of two polar bodies, indicating that Meiosis II has been 
completed, is the second most important indicator of fertilisation 
after the visualisation of pronuclei 
Table 7.1: Eggs classified as fertilised. Constructed using data gathered at ‘fert check’ 
sixteen hours post insemination. Any egg conforming to one of these descriptions was 
considered fertilised. Information sourced from (Levron et al., 1995; Veeck, 2003; Gardner 
et al., 2004; Elder and Dale, 2011). 
  
Egg status 16 hours 
post-insemination 
Considered 
receptive to 
being fertilised? 
 
Explanation of classification 
Germinal vesicle No Very immature (not yet reinitiated Meiosis I) 
No polar bodies 
visible 
No Immature (still in Meiosis I) 
One polar body 
visible 
Yes Although Meiosis I could have been completed 
at a late stage of the insemination, this cannot 
be established. Therefore these eggs are 
considered to have been receptive to 
fertilisation. 
Empty zona, 
degenerate or atretic 
egg 
No  
Absent or dying egg 
Cytoplasmically dark 
or granular 
Yes May be a sign of a post-mature egg. Prone to 
polyspermy so still receptive to sperm. 
Macro, vacuolated, 
irregular, fragmented 
polar body 
Yes Importance of egg morphology for successful 
fertilisation is debated, however, since in each 
of these categories there are some examples of 
fertilised eggs they are included in the total 
number of available eggs 
Table 7.2: Unfertilised eggs. Constructed using data gathered at ‘fert check’ sixteen hours 
post-insemination. Unfertilised eggs (that is, eggs which do not meet the criteria outline in 
Table 6.1) are classified as either ‘receptive’ to fertilisation or ‘non-receptive.’ The purpose 
of making this distinction is to ensure that only those eggs which had a genuine chance of 
being fertilised are used to calculate the final fertilisation rate. Information sourced from 
(Levron et al., 1995; Veeck, 2003; Gardner et al., 2004; Elder and Dale, 2011). 
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The IVF fertilisation rate for a cycle was considered to be: 
 
 
 
 
7.3 Statistics 
Tests of distribution were carried out using the Kolmorogov-Smirnoff test. As a number of 
variables produced data sets that were significantly different from a normal distribution 
(Table 7.3), the non-parametric Spearman rank-order correlation test (which gives a value 
of rs) was used to test for associations between variables. rs ranges from -1, though 0, to 1, 
where -1 is a perfect negative correlation, 0 is no correlation whatsoever, and 1 is a perfect 
positive correlation. The use of regression analysis, to probe for any ‘cause and effect’ 
relationship, was inappropriate here, as neither of the main variables (hyperactivation and 
fertilisation rate) were specifically set by the experiment. Statistical analysis was carried out 
using SPSS version 17. 
  
7.4 Results 
Upon calculating fertilisation rates using the method outlined in section 7.3, the spread of 
the data was found to be highly significantly different to that of a normal distribution 
(Table 7.3 and Figure 7.1). Figure 7.1 shows that data points were concentrated around the 
top end of the graph, with very low ‘outlying’ values (‘failed’ fertilisations) resulting in a 
mean which was lower than the median. 
 
No. of fertilised eggs (according to Table 7.1) 
Total number of eggs (that is, all fertilised eggs (according to Table 7.1) 
plus receptive but unfertilised eggs (according to Table 7.2)) 
x 100 
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Variable 
No. of 
observations 
 
Mean 
Std 
Dev 
 
Median 
Significantly different 
from normal 
distribution? 
Fertilisation rate (%) 81 80.1 25.2 88 Yes (P=0.01) 
Spontaneous 
hyperactivation (%) 
81 8.6 7.7 6 Yes (P=0.018) 
4-AP-induced 
hyperactivation (%) 
81 18.5 13.5 15 No (P=0.293) 
% increase in 
hyperactivation with 
4-AP 
81 219 315 145.5 Yes (P=0) 
Table 7.3: Summary of data pertaining to the primary variables explored in the IVF-
hyperactivation screen. Data gathered from 81 conventional IVF cycles was used in this 
study.   
 
  
 
 
Figure 7.1: IVF fertilisation rates. Boxplot depicts the IVF fertilisation rates calculated using 
the criteria outlined in Tables 7.1 and 7.2.   
 
82 
 
The comparison of hyperactivation expression and fertilisation rate achieved at IVF 
revealed no significant correlation between the two. This was the case for both 
spontaneous hyperactivation, and that which was induced following exposure to 4-AP. The 
values for the Spearman rank-order correlations were rs= 0.05 (P= 0.658) and rs = 0.106 (P= 
0.345) respectively (Figures 7.2 and 7.3). Similarly, no significant relationship could be 
noted between the responsiveness of cells to 4-AP, that is, the percentage increase in 
hyperactivation following application of 4-AP, and fertilisation rate (Figure 7.4).  
 
Considering only the lowest quartiles for hyperactivation levels, both those which arose 
spontaneously and those which were induced by 4-AP, the mean fertilisation rate was 77% 
for the spontaneous group (similar to the overall mean fertilisation rate of 80%), and 84% 
for the 4-AP-treated group (greater than the overall mean). This very clearly indicated the 
absence of any specific negative associations with hyperactivation and fertilisation rate. 
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Figure 7.2: Hyperactivation in untreated samples versus fertilisation rate. No significant 
correlation could be observed between the two; rs = 0.05, P= 0.658. 
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Figure 7.3: Hyperactivation in 4-AP-treated samples versus fertilisation rate. No 
significant correlation could be observed between the two; rs= 0.106, P= 0.345. 
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Figure 7.4: Percentage increase in hyperactivation following application of 4-AP. 
Response to 4-AP was calculated as ((% 4-AP-induced hyperactivation - % basal 
hyperactivation) x 100 / % basal HA). No significant correlation could be observed between 
the two; rs= 0.056 (P= 0.617). 
  
 
Upon finding no meaningful relationship between fertilisation rate and hyperactivation 
specifically, population-averaged values for individual kinematic parameters were also 
evaluated for possible associations with fertilisation. Whilst the results are not shown, 
none of the kinematic measures conventionally used to construct hyperactivation 
algorithms, that is, VCL, ALH and LIN, were significantly related to fertilisation rate 
individually. Fertilisation rate was, in fact, unrelated to all of the kinematic measurements 
recorded, which are outlined in Chapter 4.  
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7.5 Discussion 
None of the experiments carried out in this chapter demonstrated any degree of sensitivity 
or specificity; that is, ‘good’ hyperactivators failed to consistently produce high fertilisation 
rates, nor did low levels of hyperactivation in a sample did not consistently preclude 
successful fertilisation (Figures 7.2 and 7.3). No significant correlation could be established 
between fertilisation rate and hyperactivation under these experimental conditions. This 
applied to the assessment of spontaneous expression of hyperactivation in untreated 
samples, hyperactivation levels in the presence of 4-AP, and percentage increase in 
hyperactivation in response to 4-AP.  
 
The fact that the experiments carried out here yielded no indication that sperm samples 
displaying highest levels of hyperactivation fertilised oocytes in vitro most successfully is 
perhaps not entirely surprising. For example, it has previously been acknowledged that the 
highly multi-factorial nature of sperm function dictates that motility parameters alone 
cannot determine sperm fertilising potential (Tomlinson et al., 1999; Amann and Katz, 
2004). Despite established links between hyperactivation and other markers of cell 
integrity (discussed in Chapter 2), this type of motility can, for example, be readily induced 
in cells which are deficient in other parameters, like those exhibiting extremely poor 
morphology. In fact, even globozoospermic samples, despite abnormal midpiece 
structures, can hyperactivate normally (Aitken et al., 1990).  
 
Moreover, other factors influencing IVF conditions may have also masked the effects of 
‘good’ sperm and confound results in this context. Despite every attempt to exclude 
oocytes which were obviously immature or defective, possible hidden flaws, such as an 
abnormal chromosome compliment or any kind of receptor malfunction (Veeck, 2003), 
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make it difficult to assess sperm performance in a controlled manner. Split cycles (in which 
half the oocytes undergo conventional IVF and the other half are subjected to ICSI) would 
allow for better discrimination between sperm and egg factors, but their use is rare (only 
three times out of 110 cycles in the time period studied). However, even these are 
imperfect due to the heterogentity in a cohort of eggs.  
 
What could be considered more unusual than the absence of any degree of sensitivity (the 
identification of ‘true positives’) emerging from the experiments in this chapter, is that 
even sperm samples with the poorest hyperactivation levels (both in the presence and 
absence of 4-AP) fertilised eggs successfully. No threshold hyperactivation level, below 
which fertilisation rates were consistently poor, could be identified. On the contrary, the 
fertilisation rates acheived by the poorest hyperactivators were in fact equivalent to those 
of the best hyperactivators.  
  
If not even failure at IVF can be predicted, could it be that the expression of hyperactivation 
is simply not an essential prerequisite for fertilisation in humans? There is a lack of detailed 
studies on the motility patterns of sperm recovered from human fallopian tubes, and, 
understandably, ‘in situ’ studies are absent. Indeed the majority of research into the 
specific relevance of this ‘step-up’ in motility on fertilisation, that is, studies involving 
sperm recovered from the oviduct and CatSper work, has been conducted in animal models 
(Katz and Yanagimachi, 1980; Suarez et al., 1983; Ren et al., 2001; Carlson et al., 2003). 
 
 Whilst there is little conclusive data pertaining to the specific biological relevance of 
hyperactivation in humans, given its critical function in mammals and the similarities in the 
fertilisation process it seems unlikely that hyperactivation in humans could be a redundant 
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artefact. More probably, it is that the requirement for pronounced hyperactivation 
becomes less important in an IVF scenario, compared to in vivo.  
 
One possible reason for this could be that passage through the fallopian tubes and 
navigation towards the oocyte are the fundamental purposes of hyperactivation in 
humans, and not the penetration of the oocyte vestments. If this were the case then the 
simple elimination of the female reproductive tract, as in an IVF scenario, would explain 
why hyperactivation levels did not seem relevant in vitro. Much of the evidence in other 
species, however, specifically suggests that even when only the latter most barriers to 
fertilisation are present, the expression of hyperactivated motility is still an absolute 
requirement if those barriers are to be breached (Stauss et al., 1995).  
 
A more plausible rationale with which to justify successful IVF in cases where 
hyperactivation was low is that the sheer numbers of sperm around the oocyte negate the 
need for a large proportion of cells to be hyperactive. For example, by using insemination 
numbers of approximately 150 000, at least a thousand times more sperm will be present 
in the vicinity of the oocytes compared than in vivo (Elder and Dale, 2011). Under such 
conditions, a hyperactivation level of only 5% corresponds to 7500 sperm. Even supposing 
only 10% of these are functionally competent in other aspects, that still leaves 750 ‘good’ 
sperm situated in immediate proximity to the oocytes. In a volume of only 0.7ml, the 
collision rate will be high. It is therefore not difficult to see how even samples displaying 
very low proportions of hyperactivated cells can fertilise eggs comfortably, and indeed one 
of the purposes of IVF, and not just ICSI, is to make it easier for poorer quality sperm to 
fertilise eggs. The boxplot depicting fertilisation rate (Figure 7.1) is testament to the fact 
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that, when variables pertaining to oocytes were controlled (as far as was possible), 
fertilisation rate at IVF is very high.  
 
There were, even in the 4-AP treated samples, a number of hyperactivation readings which 
were recorded as very close to zero, however fertilisation was still accomplished. If the 
expression of hyperactivation is essential for penetration of egg vestments, then how did 
such samples fertilise oocytes? In these experiments, percentage hyperactivation was 
specifically defined as the proportion of cells which demonstrated movement 
characteristics comprising VCL ≥ 150µm/s plus ALH ≥ 7µm plus LIN ≤50% at the specific 
time point assessed. Such an algorithm was specifically chosen because it had been 
validated using visual and flagellar analysis of cell behaviour and was designed to 
encompass all aspects of hyperactivated movement described (Mortimer et al., 1998). 
Whilst for measurement purposes, hyperactivation of course has to be assigned some sort 
of mathematical definition; such an ‘all or nothing’ status in practice may not be truly 
representative of hyperactivation. For example, it may be that a cell with a lower than 
threshold ALH may be able to compensate by having a greater VCL, and vice versa. Subtly 
different styles of motion may all actually appear to be hyperactivated, and indeed be able 
to accomplish the same thing mechanically. Therefore, just because a sample is recorded as 
having 0% hyperactivation, it does not necessarily mean that it will be unable to effectively 
perform any of the tasks dependent on this type of motion. This may have been the case 
despite no specific relationships having been found between hyperactivation and VCL, ALH 
or LIN either.   
   
It also seems possible that the hyperactivation algorithm used was too stringent. For 
example, whilst any algorithm based around high VCL, high ALH and low LIN algorithm will 
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accomplish the task of separating the ‘best’ hyperactivators from the ‘worst’ 
hyperactivators , if the ‘worst’ perform just as efficiently at IVF as the ‘best,’ as was the 
case in this assay, then it seems possible that the criteria was set too high. In practice, the 
movement characteristics required to penetrate the cumulus and the zona may not 
accurately match those stipulated by the algorithm applied. Perhaps not even the samples 
displaying the lowest levels of hyperactivation were actually afflicted by any 
hyperactivation pathology, thereby explaining why fertilisation proceeded normally. In fact, 
hyperactivation-specific defects, that is, the inability to exhibit hyperactivated movement 
whilst activated movement appears normal, may, as noted in Chapter 5, be rare. 
 
In summary, in the context of the IVF program at the Assisted Conception Unit in Ninewells 
Hospital, no relationships were found between the expression of hyperactivated motility in 
a sample and the corresponding fertilisation rate at IVF. A hyperactivation assay based 
around the conditions used in this experiment would, therefore, be unable to predict either 
fertilisation success or failure. It would seem that there is no clinical advantage to using 
such a screen as a pre-IVF prognostic indicator in this setting.  
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Chapter 8: Effect of modulators of store-operated calcium entry on hyperactivation  
8.1 Introduction 
A wealth of evidence now points to the existence of a motility-controlling Ca
2+
 store located 
at the base of the sperm flagellum in mammals (discussed in Chapter 1). Sensitive to the 
pharmacological manipulation of ryanodine receptors, which have been localised to the 
midpiece region, it appears that in humans this store may therefore be opened by CICR 
(Harper et al., 2004; Lefievre et al., 2007). How the initial Ca
2+
 stimulus is initiated is unclear 
(Costello et al., 2009). Mobilisation of the store can be noted upon application of 
progesterone and 4-AP to human sperm (Bedu-Addo et al., 2008). 
 
It is unlikely that the action of store mobilisation alone could induce any functionally 
significant rise in intracellular Ca
2+
, nor the sustained elevation of Ca
2+
 which is particularly 
apparent upon application of 4-AP (Gu et al., 2004). For example, in nominally Ca
2+
-free 
medium , emptying Ca
2+
 storage organelles using bis-phenol or thapsigargin produces only 
a small, transient rise in [Ca
2+
]i (Blackmore, 1993; Harper et al., 2005; Espino et al., 2009). 
With respect to motility, it has also been demonstrated that the Ca
2+
 directly mobilised 
from the store can only account for the initiation of hyperactivation, and that an external 
calcium source is required to maintain it (Bedu-Addo et al., 2008).  
 
The promotion of Ca
2+
 influx via CatSper has recently been identified as one the principal 
roles of progesterone in human sperm. However, blocking CatSper current entirely, using 
the channel blocker NNC55-0396, only partially inhibited the progesterone-induced initial 
Ca
2+
 transient (Strunker et al., 2011). This indicates that a significant proportion of the Ca
2+
 
which enters the cytosol following the application of progesterone does not come through 
CatSper.  
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In somatic cells, 4-AP causes mobilisation of Ca
2+
from intracellular stores followed by Ca
2+
 
influx through plasma membrane channels (Grimaldi et al., 2001). This effect is termed 
store-operated calcium entry (SOCE), and a number of studies have indicated that it is 
active in human sperm (Williams and Ford, 2003; Espino et al., 2009).  
 
SOCE is a mechanism by which depletion of intracellular Ca
2+
 stores promotes the opening 
of ‘store-operated’ calcium channels (SOCC) in the plasma membrane. Whilst the primary 
evolutionary function of SOCE may have been the specific refilling of depleted storage 
organelles in order to maintain intracellular calcium homeostasis, it is a mechanism which 
can also play a role in the transduction of signals arising extracellularly (Putney, 1986; 
Putney, 2004). An agonist with the ability to mobilise intracellular stores can therefore elicit 
a prolonged Ca
2+
 signal in the cytoplasm.   
 
 The ‘toolkit’ for SOCE is made up of Ca
2+
 sensors and channels, with the key proteins 
identified in somatic cells being those belonging to the families STIM, Orai and TRPC 
(Parekh and Putney, 2005; Abramowitz and Birnbaumer, 2009; Costello et al., 2009; Varnai 
et al., 2009). STIM proteins serve as store-localised Ca
2+ 
concentration sensors. They work 
in concert with Orais, and possibly also TRPCs, in the plasma membrane in order to 
promote the entry of extracellular calcium ions. The mechanism of action of SOCE is 
depicted in the diagram Figure 8.1.  
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Stimulus causes opening of Ca
2+
-permeable channels on membrane of storage organelle 
↓ 
Ca
2+ 
effluxes from store 
↓ 
STIM1, also located on membrane of store, senses store Ca
2+
 depletion 
↓ 
STIM1 communicates with plasma membrane by redistributing into puncta 
↓ 
Ca
2+
-permeable plasma membrane channels formed from Orai (and possibly TRPC) proteins 
open 
↓ 
Extracellular Ca
2+
 enters the cytosol 
↓ 
Store is refilled by SERCA/SPCA and Ca
2+
 can act as a second messenger 
↓ 
Process can be repeated 
 
Figure 8.1: SOCE mode of operation. Adapted from information contained in (Parekh and 
Putney, 2005; Cahalan, 2009; Varnai et al., 2009).    
 
In humans, Western blotting and immunolocalisation have indicated that STIM and Orai 
proteins are expressed in human sperm. Orai 1 and 2 can be detected in the flagellum 
(Costello et al., 2009), and STIM1 in the midpiece (Figure 8.2).  
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Figure 8.2: STIM1 expression in human sperm. From (Costello et al., 2009). Images (a) and 
(b) show the immunolocalisation of STIM1 to the neck/midpiece of human sperm. The 
brightest spot is located in the region of the RNE (arrow in image (c)). 
 
The movement of Ca
2+ 
into the cell through plasma membrane channels involved in SOCE is 
termed ‘ICRAC’ (CRAC = Ca
2+
-release-activated calcium), and it can be manipulated using a 
number of pharmacological compounds in somatic cells. By modifying the interactions 
between the store-bound proteins and those at the plasma membrane, 2-
aminoethoxydiphenyl borate (2-APB) potentiates STIM1-Orai1 mediated ICRAC at low 
concentrations, that is, under 10µM, and inhibits it at higher concentrations, that is, up to 
50µM (Wang et al., 2009). At a concentration of 20-30µM, the imidazole SKF-96365 has 
also been shown to inhibit SOCE and ICRAC in a number of different cell lines, by a 
mechanism yet to be fully elucidated (Prakriya and Lewis, 2002; Varnai et al., 2009).  
 
Both 2-APB and SKF-96365 have been shown to influence progesterone-induced Ca
2+
 
signalling in human sperm. Recently, single-cell imaging experiments indicated that a 200s 
pre-incubation with 5µM 2-APB enhanced the Ca
2+
 transient induced by 3µM progesterone 
(Lefievre, 2011). This evidence suggests that a form of SOCE influenced by 5µM 2-APB is 
acting to promote the initial Ca
2+
 transient, in parallel with Ca
2+
 influx through CatSper 
(Strunker et al., 2011). In contrast to these results, Park et al., 2011, noted that inhibitory 
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concentrations of 2-APB and SKF-96365 (both 50µM) affected the smaller, sustained, 
midpiece Ca
2+
 signal (either a plateau or oscillations) in human sperm preparations. 
 
Whilst Ca
2+
 signalling data such as that outlined above clearly implicates SOCE in the 
alteration of sperm motility patterns, there is little evidence on the influences of 
modulators of SOCE on hyperactivation directly. Therefore, the effects of 2-APB and SKF-
96365 on hyperactivation, as measured by CASA, were investigated.  
 
 
8.2 Experimental procedures 
 
The sperm samples used in this chapter originated from research donors, all of whose 
ejaculate quality was within the normal range for concentration and motility according to 
WHO criteria as of 2009 (WHO, 1999). Sperm preparation methods and the assessment of 
hyperactivation using CASA are detailed in Chapter 4. Following preparation, sperm cells 
were resuspended in CM, the recipe for which is also presented Chapter 4. A number of 
experiments were carried out in order to monitor the effects of an agent known to 
potentiate SOCE, that is, 5µM 2-APB, and those known to have inhibitory effects on SOCE, 
namely, 50µM 2-APB and 25µM SKF-96365. Table 8.1 details the variables monitored in 
each.   
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Experiment Aliquot 
1 
Aliquot 2 Aliquot 
3 
Aliquot 
4 
Aliquot 5 Aliquot 6 
 
1 
 
Control 
3.6µM 
progesterone 
2mM 4-
AP 
50µM 2-
APB 
3.6µM 
progesterone + 
50µM 2-APB 
2mM 4-
AP + 
50µM 2-
APB 
 
2 
 
Control 
3.6µM 
progesterone 
2mM 4-
AP 
5µM 2-
APB 
3.6µM 
progesterone + 
5µM 2-APB 
2mM 4-
AP + 5µM 
2-APB 
 
3 
 
Control 
3.6µM 
progesterone 
2mM 4-
AP 
25µM 
SKF-
96365 
3.6µM 
progesterone + 
25µM SKF-
96365 
2mM 4-
AP + 
25µM 
SKF-
96365 
 Table 8.1: Pharmacological manipulations performed in order to test the role of putative 
modulators of SOCE on hyperactivation. For each experiment, sperm samples were 
divided into 6 aliquots. Drugs were only added immediately prior to CASA assessment, and 
aspirated four or five times before slide-loading to ensure homogenous distribution of both 
the drug and the cells. For aliquots 5 and 6 in each case, both drugs were added 
simultaneously, however, adding them sequentially (in either order), or pre-incubating (for 
two minutes) with one before adding the other, produced identical results to those 
depicted in section 8.4 below.      
 
 
8.3 Statistics 
No data set had a distribution which was significantly different to a normal distribution 
(determined using Kolmorogov-Smirnoff test), therefore paired sample t-tests were used to 
identify differences between variables in every case.  Statistical tests were carried out using 
SPSS verison 17. 
 
8.4 Results  
Under these experimental conditions 5µM 2-APB, 50µM 2-APB and 25µM SKF-96365 all 
failed to induce any significant differences in hyperactivation expression (Figures 8.3, 8.4 
and 8.5). This was the case both when each of the SOCE modulators was added to ‘control’ 
sperm, and when their effects were monitored in the presence of progesterone and 4-AP. 
The results displayed represent the mean values calculated across seven samples (from 
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seven donors) in each case, as this was the only way in which statistical significance in a 
population could be examined. With respect to each individual sample recorded in the 
presence or absence of 2-APB or SKF-96365, a comparison of the standard deviations 
between the four counts of 200 cells indicated that the majority of values here were not 
‘different’ from one another either. In fact, differences of a similar size can be observed 
when analysing the same preparation twice in succession (results not shown). 2-APB or 
SKF-96365 therefore did not influence hyperactivation in either a stimulatory or inhibitory 
manner under these experimental conditions. This was the case not only for 
hyperactivation, but in fact for all motility parameters recorded. 
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Figure 8.3: Effect of 5µM 2-APB on hyperactivation. Hyperactivation was first measured in 
the presence of progesterone and 4-AP. The effects on hyperactivation of 5µM 2-APB were 
then tested both in isolation and in conjunction with progesterone and 4-AP. Bars 
represent the average (plus or minus the standard error) of seven donor samples tested. 
The mean of the control group is significantly different to that of the progesterone group 
and the 4-AP treated group (P= 0.002 and P=0.018 respectively), as is the mean of the 2-
APB treated group compared to that of the progesterone + 2-APB and 4-AP + 2-APB treated 
groups (P= 0.004 and P= 0.004 respectively). However, no significant differences arose 
following the addition of 2-APB to the control, progesterone or 4-AP treated groups.  
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Figure 8.4: Effect of 50µM 2-APB on hyperactivation. Hyperactivation was first measured 
in the presence of progesterone and 4-AP. The effects on hyperactivation of 50µM 2-APB 
were then tested both in isolation and in conjunction with progesterone and 4-AP. Bars 
represent the average (plus or minus the standard error) of seven donor samples tested. 
The differences between the mean of the control group and the mean of the progesterone 
and 4-AP treated group are approaching levels of significance (P= 0.06 and P=0.07 
respectively), and the mean of the 2-APB treated group is significantly different to that of 
the progesterone + 2-APB treated group and the 4-AP + 2-APB treated group (P= 0.041 and 
P= 0.014 respectively). No significant differences arose following the addition of 2-APB to 
the control, progesterone or 4-AP treated groups.  
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Figure 8.5: Effect of 25µM SKF-96365 on hyperactivation. Hyperactivation was first 
measured in the presence of progesterone and 4-AP. The effects on hyperactivation of 
25µM SKF-96365 were then tested both in isolation and in conjunction with progesterone 
and 4-AP. Bars represent the average (plus or minus the standard error) of seven donor 
samples tested. The mean of the control group is significantly different to those of the 
progesterone group and the 4-AP treated group (P= 0.03 and P=0.001 respectively), as is 
the mean of the SKF-96365 treated group compared to those of the progesterone + SKF-
96365 and 4-AP + SKF-96365 treated groups (P= 0.007 and P= 0.001 respectively). However, 
no significant differences arose following the addition of SKF-96365 to the control, 
progesterone or 4-AP treated groups.  
 
         
 
 
8.5 Discussion 
Given that previous evidence has indicated that SOCE is active in human sperm cells 
(Blackmore, 1993; Harper et al., 2005; Espino et al., 2009), and that both 2-APB and SKF-
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96365 can influence Ca
2+
 signals (Lefievre, 2011; Park et al., 2011), the findings here that 
SOCE was unaffected by such drugs could be considered surprising. With respect to SKF-
96365, the results displayed here are contradictory to those of Castellano et al., 2003, who 
found that the application of 20µM SKF-96365 to human sperm decreased the percentage 
overall motility by 30% following a one minute incubation. Interestingly, a similar level of 
inhibition was achieved by accident here, when a concentration ten times greater than this 
was applied (results not shown). The same authors’ observation that 2-APB over a range of 
concentrations between 0.5 and 75µM was ineffective at altering motility was consistent 
with what was seen in this study.  
 
It seems unlikely that flaws in any technical aspects of the experiments could be 
responsible for masking any effects of 2-APB and SKF-96365 on hyperactivation. For 
example, whilst the integrity of each drug preparation was not tested in other cells in which 
they have established activity, chemicals were purchased from a reliable source and stored 
according to manufacturer’s instructions at all times. Moreover, once their inability to alter 
hyperactivation became apparent, fresh stock solutions were prepared in order to exclude 
the possibility of incorrect dilutions, etc. CASA analysis also seemed to be working 
correctly, as progesterone and 4-AP induced the same effects as they had done in the 
experiments carried out in Chapter 5.  
 
There is a possibility that the agents used here did not alter the expression of 
hyperactivation because their effects on SOCE were confounded by the influences they can 
also exert on other pathways involving Ca
2+
 signalling. For example, whilst both 2-APB and 
SKF-96365 have been shown to influence STIM1-Orai1 mediated Ca
2+
 influx, neither acts 
specifically on this mechanism. For example, there is evidence that 2-APB can also act at 
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IP3 receptors, and inhibitory effects of SKF-96365 on TRPC’s, VGCC’s and potassium 
channels have been documented (Varnai et al., 2009). However, the fact that previous 
investigators have observed very clear stimulatory and inhibitory effects on Ca
2+
 signals 
with these specific inhibitors at similar concentrations makes this less likely to be the 
reason that no effects on hyperactivation could be noted.   
 
Therefore, assuming previous investigators are correct in their observations that SOCE is 
operational in human sperm, and that 2-APB and SKF-96365 do affect Ca
2+
 signals, what 
rationalisation could be offered as to why hyperactivation, or indeed any motion 
parameters, were unchanged by these modulators of SOCE under the experimental 
conditions applied here? 
  
With respect to the comparison between the control (no drugs added) and the 2-APB 
treated groups in all three experiments, the lack of change in hyperactivation could 
possibility be explained by the fact that, in the absence of agents which specifically induce 
store mobilisation, the proportion of sperm that were undergoing store-mediated Ca
2+
 
signalling in the first place was so small that modulation of SOCE by 2-APB and SKF-96365 
was minimal. However, such a theory is put into question by the finding that 2-APB has the 
ability to elevate even resting [Ca
2+
]i (Lefievre, 2011). In any case, what is certainly more 
unusual is that a similar lack of both stimulatory and inhibitory effects was also apparent 
even after stores were purposely mobilised using progesterone or 4-AP.  
 
Considering progesterone treated samples, one research group have found that the 
amplitude of the immediate, transient rise in Ca
2+
 induced by 3µM progesterone is 
significantly increased in the presence of 2-APB (Lefievre, 2011). Moreover, this effect was 
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particularly pronounced in samples whose response to progesterone alone was relatively 
weak. These findings offer two potential explanations as to why 2-APB failed to influence 
hyperactivation in the presence of progesterone. Firstly, if the action of SOCE induced by 
progesterone is to modify the initial calcium transient, then it may be the case that any 
action was undetectable after the minute or so that it takes to obtain a reading following 
slide loading (discussed in Chapter 4). Secondly, the overall percentage increase in 
hyperactivation between the control and progesterone treated samples in these 
experiments was more than double what it was for the samples screened in Chapter 4: 53% 
(progesterone group significantly different to control) vs 22.7% (progesterone group not 
significantly different to control) respectively. This perhaps suggests that the sperm 
samples used in this chapter were particularly good progesterone responders in the first 
place, rendering any additional effects of 2-APB essentially negligible.  
 
If SOCE acts to increase not the initial Ca
2+
 transient but the subsequent sustained phase of 
the progesterone-induced Ca
2+
 signal (Park et al., 2011), then it is unusual that 2-APB and 
SKF-96365 did not modify hyperactivation, as, temporally, this phase should be able to be 
captured by CASA. The same can be said of the 4-AP treated samples. If the 4-AP-induced 
prolonged elevation of intracellular Ca
2+
 (which is accompanied by a sustained period of 
hyperactivation) is SOCE mediated, then why did drugs which influence SOCE not modify 
the hyperactivation response, perhaps in particular why were no inhibitory effects seen 
when levels were very high?  
 
It is quite possible that, whilst 2-APB and SKF-96365 may be altering Ca
2+
 signalling patterns 
in human sperm, their effects are either not directly altering flagellar activity, or it is not 
possible to monitor these changes simply with CASA. Perhaps the observation of flagellar 
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movement in single cells at the exact point of application of the SOCE-influencing drug 
would help to establish whether or not SOCE truly was involved in promote motility 
changes (procedure for this described in Harper et al., 2004). Further studies are needed, 
but if such work did indeed implicate SOCE in the generation/maintenance of 
hyperactivated motility, then specific dysfunction in store-mediated Ca
2+
 signalling may be 
identified as a novel cause of asthenozoospermia in a proportion of infertile men.  
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Chapter 9: General discussion and outlook 
The primary goals of this project were: to find the most appropriate way of accurately 
recording hyperactivation, to explore the incidence of hyperactivation in men from 
different populations, to probe for direct links between hyperactivation and fertilising 
capacity, and to interrogate the mechanism of sperm motility signalling via stored Ca
2+
.  
 
A large amount of time was dedicated to understanding how CASA can be used to produce 
repeatable and reliable results with respect to the assessment of sperm motility 
parameters (detailed in Chapter 10). Therefore, when results emerged which supported the 
null hypothesis in Chapters 7 and 8 (i.e. that hyperactivation was not linked to fertilisation 
in vitro and that modulators of SOCE did not alter the expression of hyperactivation) it 
seems unlikely that inaccurate measurements were the cause of this. 
  
With respect to Chapter 7, it was in fact recognised from the outset that the clinical 
potential of a pre-IVF hyperactivation screen would be limited. The field of andrology has 
changed a great deal since the original concept of sperm function testing emerged. Central 
to this change was, of course, the advent of ICSI (Palermo et al., 1992). By circumventing 
the normal path to fertilisation entirely, ICSI essentially removed the need for sperm cells 
to ‘function’ at all; a nucleus containing genetic material was all that was required. Whilst 
in the 1980’s and early 90’s, the objective of assaying hyperactivation may have been 
primarily to explore ways in which to improve conventional IVF, for example, by using high 
insemination concentrations or by pre-treating sperm with heat or pharmacological agents, 
(Mortimer and Mortimer, 1992; Tournaye et al., 1994; Fishel et al., 1995; Chan et al., 1998), 
as soon as ICSI became widespread, the need for such measures was negated. ICSI practice 
has, over the last fifteen years, ‘exploded’ in Europe, rising from 34.75% (of all treatment 
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cycles carried out) in 1997 to 63.3% in 2005 (Nyboe Andersen et al., 2009); an increment 
which reflects not a rise in male infertility but a resistance amongst embryologists to ‘risk’ 
conventional IVF if they have any doubts regarding the quality of the sperm sample and its 
potential to generate a good fertilisation rate.  
 
What this means in practice is that patient selection for IVF nowadays is very different to 
what it was during the time when the ‘buzz’ surrounding assays of sperm function led to 
the conduction of clinical hyperactivation studies such as those performed by Chan et al. in 
1998, Guerin et al, in 1995 and Sukcharoen et al., in 1995. For example, whereas in the 
90’s, men who presented with confounding factors such as poor/borderline progressive 
motility and/or morphology may have been included in such hyperactivation-IVF screens, 
these patients would now be directed straight to ICSI.  
 
Arguably, sperm function tests could be considered more important in the current era of 
assisted reproductive technology, as embryologists now have to make a choice between 
IVF and ICSI, as opposed to only having the option of conventional insemination. However, 
these tests would really only be of use in the current era of assisted reproduction if they 
were able to pick out ‘occult’ hyperactivation pathologies, that is, those which existed 
against the background of an entirely normal semen analysis. Otherwise, assaying 
hyperactivation will be redundant, as the sample in question will have already been 
scheduled ICSI for another reason.  
 
Therefore, whilst it was conceded that a hyperactivation screen may only have the 
potential to identify a small proportion of fertilisation failures, perhaps too few to be 
picked up in a sample size of less than 100, what was surprising was that even samples with 
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hyperactivation levels which measured close to zero under these conditions were able to 
fertilise eggs. The most likely explanation for this, from those offered in Section 7.5, is that 
the numbers of sperm used for insemination were too high for any deficiencies in 
hyperactivation to present a problem. However, it is certainly possible that samples 
displaying low levels of hyperactivation will face a genuine disadvantage under in vivo 
conditions, with fewer numbers of cells being able to reach even the surface of the oocyte. 
There may be scope, therefore, to examine the role of a hyperactivation screen in 
selecting, or more importantly, deselecting, couples for ovulation induction or IUI.    
 
There is still some debate amongst the embryology community regarding the use/overuse 
of ICSI. However, unless any serious detrimental health aspects come to light in the future 
generations of ICSI babies, it will remain popular and effective tool in IVF. Embryologists, 
when faced with either carrying out an array of sperm function tests, or proceeding straight 
to ICSI, are likely to pick the latter.   
 
Therefore, should the focus of clinical sperm research now be directed more towards 
improving the selection of sperm for ICSI? Whilst sperm functional capacity in ICSI is 
negligible, the integrity of the paternal genome has been shown to be contributory to not 
only fertilisation, but crucially, the developmental fate of the embryo (Avendano et al., 
2010; Lewis and Simon, 2010; Simon et al., 2010). Abnormal sperm DNA can be take the 
form of chromosomal alterations such as aneuploidies, incomplete remodelling of 
chromatin during packaging, or strand breaks caused by oxidative damage. As men whose 
semen parameters are poor are more likely to produce sperm cells which have damaged 
DNA, in an ICSI cycle there is a greater chance of introducing a genetically flawed paternal 
genome into the oocyte (Oehninger and Kruger, 2007). Whilst assays which detect DNA 
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fragmentation, such as TUNEL, Comet and SCSA, or those which detect aneuploidy such as 
FISH, are useful for diagnosing male infertility and predicting IVF outcome (Simon et al., 
2011), they cannot help with the real time selection of genetically normal individual cells.  
Current practice of ICSI typically involves the selection of sperm at 400x magnification. 
However, with the use of specialised contrast optics and a magnification of over 6000x, it is 
now possible to examine live, motile sperm at the organelle level. Sperm selected using this 
method prior to their microinjection (‘IMSI’) have been shown to have less DNA 
fragmentation, and to produce fewer aneuploid embryos, than those which would 
otherwise have been selected for standard ICSI (Figueira Rde et al., 2011; Wilding et al., 
2011). Correspondingly, results suggest that this results in significant increases in 
implantation and pregnancy rate (Berkovitz et al., 2005; Setti et al., 2010), perhaps 
particularly in men with poorest quality semen (Balaban et al., 2011). There is another way 
in which sperm with fewer genetic aberrations may be selected for ICSI; a technique 
referred to as PICSI™. This method works on the principal that mature sperm are less likely 
to present with DNA fragmentation, incomplete chromatin remodelling or chromosomal 
abnormalities. As only mature sperm can effectively to bind to solid-state hyaluronic acid, 
the substance is used as an indicator for high intergrity sperm (Oehninger and Kruger, 
2007). Such advances may therefore optimise treatment outcomes for both moderate and 
severe male factor patients, and even patients whose semen analysis is normal yet whose 
DNA status is compromised.        
 
The presence of sperm DNA damage may actually have a specific connection to 
hyperactivation also. Sperm cells produce reactive oxygen species which are known to play 
a role in the induction of both hyperactivation and capacitation. However, this involves a 
critical balancing act between ROS generators and ROS scavengers, as the production of 
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too much ROS at an inappropriate time can have a detrimental effect on sperm function 
(De Jonge and Barratt, 2006). When hyperactivation occurs spontaneously, that is, in 
semen as opposed to in the female reproductive tract or a medium of similar chemical 
constituents, it may reflect the fact that the sample has a low ROS scavenging capacity (de 
Lamirande et al., 1997). Cells in such an environment will clearly be under increased 
oxidative stress. This may not only affect their functional capacity, but also directly damage 
their DNA. In this respect, hyperactivation may serve as a marker with which to identify a 
sample at risk of having a higher proportion of damaged DNA. Whilst this would only be 
useful for diagnostic purposes at present, there may, in the future, be a way to treat and/or 
prevent the effects of free radical attack. 
 
With respect to the elucidation of the signalling pathways responsible for the control of 
hyperactivation, such as the putative role of SOCE, more work is required. Understanding 
the nature of all aspects of sperm function has important implications for male fertility. For 
example, it may be possible to treat a proportion of sperm disorders therapeutically. If such 
breakthroughs could be made, it may diminish the need to consistently resort to ART, 
which is expensive, invasive, and whose long term effects on the health of future 
generations are unknown. Equally importantly, research into the workings the sperm cell 
will be crucial in the identification of drug targets which could be exploited by non-
hormonal male contraceptives. Indeed, CatSper is being hailed as a candidate for such a 
role at present (Hildebrand et al., 2010).    
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Chapter 10: Appendix 
10.1 Evolution of methods 
From initial observations and the study of previous published work it was recognised that a 
number of variables may affect both the expression of hyperactivation in a sample and its 
measurement using CASA. Without careful control of these variables, making a reliable 
comparison of hyperactivation levels between samples, or before and after 
pharmacological manipulation of a sample, would be very difficult. Moreover, if, even after 
controlling all variables, repeatable and reliable results could not be attained, then it was 
acknowledged that the assessment of hyperactivation may be inherently too inaccurate to 
be used as a transferrable assay. 
 
In order to adequately standardise the testing methods, and determine the optimal 
conditions under which hyperactivation should be assessed, the method outlined in the 
methods section was developed and optimised in the weeks prior to gathering any data 
from clinical samples.  
 
The factors that could influence the expression and measurement of hyperactivation were 
proposed to be those outlined in Table 10.1.  
Definite variables Probable variables Possible variables 
Medium  Temperature  Concentration of sperm cells  
CASA settings  Incubation period  Sperm preparation method  
 Number of cells counted   
Table 10.1: Putative variables affecting the expression and measurement of 
hyperactivation.  
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Sperm samples produced by research donors were used to test the effects of each 
parameter in the table above, and these were varied independently. 
10.1.1 Medium 
As the expression of hyperactivation requires H
+
CO3
-
, Ca
2+
 and glucose, the concentration at 
which these components are present in the extracellular medium is likely to have a crucial 
influence on its expression. Media designed to support capacitation may also be richer in 
other components which play a role in the initiation and maintenance of hyperactivation. 
They may also be more alkaline in pH, thereby potentiating CatSpers.  
Clinical samples received from the embryology laboratory arrived in either Cook Sperm 
Medium™ (if the sample was used in conventional IVF) or Cook Gamete Buffer™ (if the 
sample was used in ICSI). Sperm Medium is bicarbonate-buffered, pH 7.5-7.8 when 
equilibrated with sufficient CO2, and designed to support capacitative events. Gamete 
Buffer is HEPES based, held at pH 7.3-7.5, and is for use in a situation where capacitation of 
sperm is not required (e.g. in ICSI).  
Hyperactivation levels in the two media were compared, whilst all other variables in Table 
10.1 were kept constants. Results are shown in Figure 10.1. 
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Figure 10.1: Hyperactivation in capacitating and non-capacitating clinical media. Error 
bars represent the standard deviation between four counts of 800 cells.    
 
The results show unsurprisingly that the levels of hyperactivation were significantly greater 
(paired samples t-test, P= 0.01) in samples suspended in Sperm Medium compared to 
Gamete Buffer. Mirroring these results were those obtained for hSTF (capacitating) and 
NCB (non-capacitating), with the commercial media inducing only slightly elevated rates of 
hyperactivation (not significantly different) compared to their laboratory-synthesised 
counterparts (results not shown). Only like for like medium was used to monitor the effects 
of other variables on hyperactivation to exclude the possibility of extra variables being 
introduced in this way.     
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10.1.2 CASA settings 
Image frame rate and number of frames recorded were standard for the CEROS machine. 
All other aspects of setup were checked every day prior to using the CASA, to ensure that 
they were kept constant throughout the data recording.   
 
10.1.3 Temperature 
Early studies of hyperactivation indicated that hamster sperm hyperactivated more readily 
at 37
o
C than at room temperature (approx 24
o
C) (Mahi and Yanagimachi, 1973). 
Conversely, another study carried out in 1989 suggested the opposite; that hyperactivation 
decreased when moving from 24
o
C to 37
o
C (Mack et al., 1989). The authors proposed that 
it might due to an effect of temperature on calcium flux; however, this effect was also 
noted in this study when the hyperactivation algorithm was varied. Interestingly, if the VCL 
component of the hyperactivation algorithm is set too low, then cells that are simply 
struggling to swim forward, which results in the ALH value increasing, are incorrectly 
identified as hyperactivated (own observations).  
When a microscope slide at room temperature is placed on the CASA heated stage there is 
a lag period before it equilibrates to 37
o
C. Figure 10.2 depicts how long it takes for sperm 
on a ‘cold’ slide to express their maximal levels of hyperactivation. This time almost 
corresponds exactly to the time it takes for the stage to warm a slide to 37
o
C. Pre-warming 
of the slide and cover slip negates the need for any lag period, and assessment can begin 
within 30s (results not shown). Therefore all microscope slides used in this experiment 
were pre-warmed, to ensure cells were only recorded at 37
o
C.   
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Figure 10.2: Effect of temperature on hyperactivation. The point at which hyperactivation 
levels start to plateau (around 120 seconds) corresponds with the time it takes for a cold 
slide to heat to 37
o
C following its placement on a heated stage.  All other variables in Table 
10.1 were kept constant. 
 
 
10.1.4 Incubation period 
To become capacitated sperm must spend a period of time (thought to be anywhere 
between one and six hours) either in the female reproductive tract or in vitro in a 
capacitating medium. Whilst capacitation and hyperactivation may not share the same 
underlying signalling pathway, a prerequisite for observing the maximal levels of 
hyperactivation in a sample may also involve an incubation/priming period in medium. This 
was investigated by monitoring samples for hyperactivation levels at t=0, 2, 4 and 6 hours 
(Figure 10.3). 
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Figure 10.3: Variation of hyperactivation with time spent in capacitating medium. Results 
shown represent time incubated in commercial medium, that is Cook Sperm Medium™, 
however the results obtained for the home made medium (CM) mirrored these.     
 
No statistical differences could be found between hyperactivation levels recorded at 
different time points (one-way ANOVA, P= 0.997). Speculatively, this suggests either that 
capacitation occurs very rapidly in vitro, or that capacitation is not an essential prerequisite 
for hyperactivation. In practice, this means that hyperactivation in samples can be 
compared as like for like regardless of their incubation time period. There may be a danger 
that sperm left for too long will start to either run out of energy or ‘burn out’ and for this 
reason measurement time was restricted to within eight hours of preparation, as no 
deterioration was noted by this time point (results not shown).   
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10.1.5 Number of cells counted 
In counting cells to assess what proportion of a sample exhibits a specific feature (e.g. in 
terms of  motility, morphology or vitality) it has been highlighted that duplicate counts of 
only 100 cells result in large confidence intervals between values (WHO, 1999). The 
significance of this may even be enhanced when dealing with the measurement of 
hyperactivation because it is a parameter which, unlike e.g. morphology, is not fixed, but 
biphasic. Figure 10.4 highlights that counting only 100 cells, as previous investigators have 
done, may not generate an accurate value for the true percentage of hyperactivation in a 
sample. Since CASA assessment is so quick, there seems no reason not to count 800 cells.  
 
Figure 10.4: Variation in hyperactivation based on number of cells counted. The bars 
represent the average co-efficient of variation obtained from when CASA was used to make 
duplicate assessments of hyperactivation using different cell counts of one sperm sample. 
 
10.1.6 Concentration  
The tracking of sperm heads using CASA could be complicated by having too many cells 
present in each frame, for example if separate cell trajectories became so close together 
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that the system became unable to identify an individual sperm’s trajectory because there 
were other cells in its ‘search radius’ (Mortimer, 1997). This may lead to track points being 
lost and cells omitted from the analysis. In addition, it seems possible that in densely 
populated samples may behave differently to sperm which are more spaced out, for 
example as a result of greater net numbers of reactive oxygen species that may be 
generated (de Lamirande et al., 1997).  
 
Figure 10.5: Vatiation in hyperactivation with sperm cell concentration. Results shown are 
the levels of hyperactivation in four donor samples tested at different sperm cell 
concentrations. Error bars represent standard deviation between four counts of 800 cells.  
 
Figure 10.5 demonstrates that no significant differences (one-way ANOVA, P=0.984) were 
found when assaying hyperactivation at different concentrations. 10-20M/ml was 
therefore chosen as the optimal concentration at which to measure hyperactivation as it 
will permit the rapid assesment of 800 cells, whilst still maxisiming the use of each sperm 
sample.  
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10.1.7 Sperm preparation method 
As density gradient centrifugation is known to produce a higher yield of motile cells than 
the swim up technique (Bjorndahl et al., 2010) (and does not cause any damage to sperm 
cells) this method of preparation was kept constant throughout the data gathering.  
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10.2 Consent form for patient/donor participation in research 
ASSISTED CONCEPTION 
UNIT 
NHS TAYSIDE 
WARD 35 NINEWELLS HOSPITAL 
 DUNDEE DD1 9SY 
 
 Direct line (01382) 632111 
Fax (01382) 633853 
CONSENT FORM FOR PATIENTS/DONORS  
[producing extra semen samples]   
Title of research: Understanding the regulation of human sperm function and the 
development of novel treatments for male infertility. 
First of all we would like to thank you very much for taking part in our research project. 
The aim of this study is to understand how a sperm cell is activated in response to 
secretions from the female tract - progesterone and nitric oxide and to understand if this 
activation is abnormal in some men. In addition we would like to test enzyme inhibitors to 
see if we can enhance sperm motility and hope that in the future we may be able to 
develop drugs which may be able to improve IVF success. 
You may decline to take part, or withdraw at any time without this affecting, in any way, 
your treatment and care now or in the future. 
I have fully understood what will be involved in the project.  This study involves me 
producing a semen (sperm) sample by masturbation in the Assisted Conception Unit or by 
arrangement at home, for the research purposes of the project.  In the future there may be 
requests for further semen samples. 
 
Signed……………………………………………………………………………………. 
Name (block capitals)…………………………………………………………………….. 
Date………………………………………………………………………………………… 
Witnessed…………………………………(name)………………………………Signature 
 
If you have any further queries or questions you can contact either: Mr Steven Mansell 
(01382 660111 ext. 33605) or Nurse Evelyn Barratt,  e.barratt@dundee.ac.uk 
